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1 Introduction 
1.1 Hypoxic pulmonary vasoconstriction (HPV) 
1.1.1 Physiological relevance 
Hypoxic pulmonary vasoconstriction (HPV), also known as the von-Euler-Liljestrand-
mechanism, is an essential physiological response of the lung in order to match blood 
perfusion to alveolar ventilation. It optimizes pulmonary gas exchange under conditions of 
local alveolar hypoxia. Impairment of this mechanism during pathological situations in 
pulmonary and systemic diseases (e.g. adult respiratory distress syndrome [ARDS] [1], 
hepatopulmonary syndrome [2]) or during anesthesia [3], may result in insufficient arterial 
blood oxygenation. Under conditions of chronic hypoxia, as it occurs at high altitude or during 
respiratory diseases (e.g. chronic obstructive pulmonary disease [COPD], lung fibrosis) 
generalized vasoconstriction of the pulmonary vasculature in combination with hypoxia-
induced vascular remodeling may lead to pulmonary hypertension with subsequent right 
heart hypertrophy.  
HPV is a highly conserved mechanism, present in most mammals [4-7], partially in reptiles 
[8] and probably even in fish [9]. Although an increase in pulmonary arterial pressure (PAP) 
in response to alveolar hypoxia was recognized over 100 years ago [10, 11], it was von Euler 
and Liljestrand in 1946 who suggested [12], that ventilation-perfusion matching was the 
purpose of this response. Subsequently HPV was demonstrated to be present in humans, 
determined by a 50% increase in pulmonary arterial resistance to an alveolar pO2 below 50 
mmHg (~ 7 % O2) [13].  
Despite the recognition of this mechanism decades ago, the underlying O2 sensing and 
signal transduction processes have not been fully resolved. Neither the O2 sensing process 
nor the exact pathway underlying HPV has been fully deciphered yet. As O2 sensors 
mitochondria, nicotinamide adenine dinucleotide (phosphate) oxidases (NAD[P]H oxidases) 
and cytochrome P450 have been proposed. They are thought to communicate with the 
effectors, which are different ion channels of the plasma membrane via redox state, reactive 
oxygen species (ROS) or other mediators. 
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Figure  1.1 Ventilation-perfusion matching 
Under physiological conditions, alveoli are equally ventilated and perfused, so that the blood is 
optimally oxygenated (A). During alveolar hypoxia less well oxygenated blood decreases total 
oxygenation of systemic arterial blood (B). HPV provides for lower perfusion of badly ventilated areas, 
thereby decreasing the amount of less well oxygenated blood in the systemic arterial blood (C). 
 
 
1.1.2 Characteristics of HPV - effector and sensor cell type 
HPV occurs within seconds and has been found in vivo and in explanted lungs of different 
species to start at mild hypoxia, in rabbit lungs at alveolar O2 concentrations ≤ 10% (pO2 ≤ 75 
mmHg) [5, 14].  It shows a sigmoidal stimulus-response relationship to different degrees of 
alveolar hypoxia with an onset at 7-10% O2  ( ~ pO2 50-75 mmHg) and half-maximal 
response at 3-7% O2 ( ~ pO2 25-50 mmHg) [5, 7].  
Although there are divergent results regarding the influence of precapillary pO2 on HPV, it is 
commonly accepted that HPV is mainly determined by alveolar pO2. In studies in rabbits 
neither retrograde nor anterograde perfusion of vessels with hypoxic buffer (3% O2, pO2 23 
mmHg) with or without blood did influence vessel tone, whereas inhaled gas changes from 
21-0% O2 (pO2 158 to 0 mmHg) resulted in a sigmoidal dose-response of HPV [5].  
The precapillary smooth muscle cell layer of the resistance vessels with a size of 80-600 µm 
depending on the species, which is located at the entrance of the acinus in close contact with 
alveoli has been identified as the effector and sensor cell-type for HPV [15-18]. Less 
importance was assigned to the conduit arteries, smaller, partially muscularized [15] and 
postcapillary vessels [16-20]. 
 
In line with these studies, hypoxic exposure causes isolated pulmonary arterial smooth 
muscle cells (PASMC) 1) to contract, 2) to increase their intracellular calcium concentration, 
and 3) to decrease their plasma membrane potential difference. In contrast, smooth muscle 
cells derived from isolated cerebral arteries and renal artery rings expand upon exposure to 
hypoxia [21-23] and mesenteric arteries do not decrease their plasma membrane potential 
difference in response to hypoxia [24].  
A B C 
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Hypoxia-induced responses in PASMC occur at O2 levels below O2 concentrations of 3-7% 
O2  ( ~ pO2 20-50 mmHg) [21, 25, 26]. The discrepancy to the hypoxic level initiating HPV in 
isolated organs of 7-10 O2  ( ~ pO2 50-75 mmHg) may be due to diffusion limitation of O2 from 
the alveoli to PASMC in precapillary vessel of the isolated organ or priming factors in the 
isolated organ. 
 
Factors modulating HPV include gender, local and circulating vasoactive substances, pH, 
pCO2 [27, 28] and red blood cells, but there was an early consensus that the mechanism 
itself was independent from neural [29] or humoral [30, 31] triggers. 
 
In contrast to the response in acute hypoxia, for sustained hypoxia, that lasts several minutes 
to hours, a contribution of endothelial cells must also be taken into account [32, 33]. 
Sustained HPV may be a transitory state leading to chronic hypoxic alterations, like vascular 
remodeling and chronic pulmonary hypertension. 
 
 
1.1.3 Mechanism of HPV - effectors, mediators, sensors 
The effector pathway is suggested to include L-type calcium channels, non-specific cation 
channels (NSCC) and voltage-dependent potassium (Kv) channels, whereas mitochondria 
and NADPH oxidases are discussed as O2 sensors. ROS, redox couples, and adenosine-
monophosphate-kinase (AMP kinase) are under investigation as mediators of HPV.  
 
1.1.3.1 Effector pathway 
The pathways leading to contraction of the PASMC converge in an intracellular calcium 
increase and include the influx of extracellular calcium and probably release of intracellularly 
stored calcium [34]. 
There is evidence that calcium influx from the extracellular space is achieved by both, L-type 
calcium channels [35, 36] and NSCC. Consistent with this suggestion, inhibition of L-type 
calcium channels only partially abolished HPV [37, 38], whereas inhibition of NSCC 
completely inhibited HPV [39-41]. Hypoxic regulation of the L-type calcium channels may be 
achieved by direct modulation via ROS or membrane depolarisation via potassium channels 
(as stated very early [42-44]) and NSCCs.  
Different types of potassium channels have been demonstrated to be involved in hypoxia-
associated membrane depolarization, particularly the Kv channels, Kv2.1, Kv1.5, Kv9.3 [45-
47], which have been suggested to initiate HPV. The concept of Kv channels being directly 
regulated by redox-changes has been proposed early [43]. The Kv channels may be 
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regulated by 1) reducing agents [48-51] like reduced glutathione (GSH) [52] 2) an associated 
hemeprotein [24], 3) membrane depolarization, 4) phosphorylation by kinases [53], 5) 
mitochondrial adenosine triphosphate (ATP) [54] or 6) calcium increase triggered by 
intracellular calcium release from intracellular stores or via NSCCs [53]. This is consistent 
with the observation, that the intracellular calcium increase induced by hypoxia has been 
proposed to play an obligatory role in hypoxic inhibition of potassium currents [55, 56]. 
Furthermore, only partial inhibition of HPV in potassium channel knock-out animals suggests 
that this may not be the sole mechanism of HPV [57].  
Thus NSCCs may be key channels for hypoxic signaling as e.g. in the regulation of 
potassium channels, of L-type calcium channels or the calcium level [41]. They consist of a 
group of store-operated (SOCs) and receptor-operated calcium channels (ROCs), and their 
molecular identity has been revealed as transient receptor potential (TRP) channels. The 
ROCs can be activated by protein kinases and diacylglycerol (DAG). Recently it was 
demonstrated that this mechanism is essential for acute HPV, occurring within seconds to 
minutes, as TRPC6 knock-out mice have no HPV or hypoxia-induced intracellular calcium 
increase or membrane depolarisation [58].  
The SOCs play a role in capacitative calcium entry (CCE), a calcium influx from the 
extracellular space that can be induced by emptying intracellular stores, and has been shown 
to be activated in HPV [41, 59]. While CCE is a phenomenon observed in several types of 
systemic arteries, its coupling to contraction appears to be of particular importance in 
pulmonary arteries [60], but its exact impact on HPV has not yet been resolved, especially 
due to the lack of specific experimental manipulation methods [41].  
An initial release of calcium from intracellular stores was also suggested as a key trigger for 
HPV as an hypoxia-induced increase in intracellular calcium even after removal of 
extracellular calcium has been shown. The initial intracellular calcium increase was proposed 
to originate from a calcium release from ryanodine-sensitive (RyR) calcium stores [61] with 
calcium buffering of inositolphosphate 3 (IP3) sensitive stores [26, 62, 63]. Recently it was 
shown, that hypoxia-induced calcium release and contraction was reduced in PASMC of 
type-3 ryanodine receptors knock-out mice [64]. Debate continues regarding how they might 
be regulated and if the observed increase of intracellularly released calcium may be 
restricted to PASMC of non-resistance pulmonary arteries with a large diameter [58]. 
Ryanodine-sensitive receptor channels in other cell types are modulated by calcium [64], 
redox-regulating systems [65], ROS [66, 67] and cyclic adenosine diphosphate (cADP)-
ribose [68], whereas IP3 receptor channels are regulated via cyclic guanosine 
monophosphate (cGMP) and reduced nicotinamide adenine dinucleotide (NADH) [69].  
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Figure  1.2 Effector mechanisms of HPV  
Intracellular calcium increase might be triggered by non-specific cation channels, L-type Ca2+-
channels and Kv-channels. However, only genetical deletion of the TRP6 subtype of NSCC, results in 
a complete inhibition of HPV (full line), in contrast to Kv -channel deletion or L-type Ca2+-channel 
inhibition (dashed line). 
AMP: adenosine monophosphate, ATP: adenosine triphosphate, Ca2+: calcium, cADP: cyclic 
adenosine diphosphate, CCE: capacitative calcium entry, cGMP: cyclic guanosine monophosphate, 
DAG: diacylglycerol, HPV: hypoxic pulmonary vasoconstriction, IP3: inositol triphosphate, Kv: voltage 
dependent potassium, k/o. knock-out, NADH: reduced nicotinamide adenine dinucleotide, NADPH: 
reduced nicotinamide adenine dinucleotide phosphate, PK: protein kinase, ROC: receptor-operated 
channel, ROS: reactive oxygen species, RyR: ryanodine receptor, SOC: store-operated channel, TRP: 
transient receptor potential, ∆ψ: plasma membrane potential.  
 
 
1.1.3.2 Mediators: Reactive oxygen species (ROS) and redox state 
As concluded from the above, one main modulator of the effector pathway could be the 
cellular redox state and/or ROS. The overall redox state of the cell is determined by the 
concentration of ROS and the availability of reducing equivalents, such as reduced/oxidized 
nicotinamide adenine dinucleotide (phosphate) (NAD[P]H/NAD[P]+), reduced/oxidized 
glutathione (GSH/GSSG), and is compared to extracellularly rather reduced. 
Intracellular Ca2+ ↑
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L-type Ca2+-channels 
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Cation Channels 
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L-type Ca2+-channel 
inhibitors 
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PK, ATP 
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Intracellular stores 
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?
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PK 
effectors 
mediators 
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potential mitochondrial pathway (see figure 3) 
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?
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ROS, possibly involved in O2 sensing, include superoxide (O2-), hydrogen peroxide (H2O2), 
and reactive nitrogen species. Besides being highly toxic for the cell in high concentrations 
and being regarded rather as by-products in O2 metabolism, in low concentrations of the 
pico- or low nanomolar ranges they now have been postulated to play a role as diffusible 
mediators in intracellular signal transduction.  
ROS interfere with cellular functions by modifying mainly heme or thiol redox-regulated 
systems, including guanylate cyclase, cytochromes of the mitochondrial electron transport 
system, cyclooxygenases, protein kinases like protein kinase C (PKC) and 
calcium/potassium channels [70, 71]. Important ROS producing systems are NAD(P)H-
oxidases, mitochondria, nitric oxide (NO) synthases and cytochrome P450. Intracellular 
balance of the ROS concentration is achieved by detoxification through catalase, superoxide 
dismutases (SODs) and redox systems of the cell, like glutathione and NAD(P)H. 
ROS concentration is therefore a result of the homeostasis between activation of ROS 
producing systems, O2 tension and ROS degrading processes.  
 
Although there is wide consensus regarding the importance of ROS in O2 sensing, two 
opposing hypothesis are offered for ROS regulation during HPV: Whereas one concept 
favors Kv channel modification by a reduced level of ROS as trigger for contraction, another 
concept proposes an increase in ROS during hypoxia originating from mitochondria or 
NAD(P)H oxidases (for review see: [72-76]).   
 
1.1.3.2.1 Application of oxidants and antioxidants 
 
Application of oxidants and antioxidants was used to elucidate the reactivity of the pulmonary 
vascular system with regard to HPV. 
Based on studies with the relatively unspecific oxidizing agent diamide causing vasodilation 
and inhibiting HPV in the isolated lungs [77, 78], a decrease of ROS in HPV was early 
suggested [79]. In line with this finding, antioxidants contract normoxic pulmonary artery 
vessel and inhibit potassium channels [48]. These results were challenged in isolated lungs 
by studies with antioxidants and inhibitors of SOD that specifically inhibit HPV, but do not 
induce vasoconstriction during normoxia, suggesting an increase of H2O2 during hypoxia [80, 
81]. In isolated pulmonary arteries increase of ROS by xanthine oxidase reaction during 
normoxia was shown to cause contraction through activation of PKC [82].  Application of the 
thiol-reducing agent dithiothreitol during the sustained phase of HPV reversed hypoxic 
vasoconstriction, whereas the superoxide scavenger nitroblue tetrazolium prevented further 
pulmonary vasoconstriction during the sustained phase of HPV, but did not reverse it [66]. 
Studies with exogenous H2O2, suggesting an increase of ROS during HPV, for example in 
isolated pulmonary arteries [83],  have to be judged critically with regard to rather multiple 
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effects of H2O2 in the cell and use of supra-physiologic dosages. In general the discrepancies 
of the studies may result from the possibility that the applied agents reach only parts of the 
vasoreactive pathways without necessarily affecting the physiologic pathway activated during 
hypoxia.  
 
Another study demonstrated that overexpression of glutathione peroxidase, cytosolic or 
mitochondrial catalase attenuated the hypoxia-induced increase in ROS signaling and 
intracellular calcium, whereas mitochondrial matrix-targeted Mn-SOD (which decreases 
superoxide, but increases H2O2) augmented intracellular calcium [84]. This suggests that 
superoxide production, leading to H2O2 being released from mitochondria, contributes to the 
hypoxia-induced increase in intracellular calcium.  
In summary, detailed pharmacological interventions provided evidence for both an 
upregulation as well as for a downregulation of superoxide, and subsequently H2O2, as the 
underlying pathway of HPV. 
 
1.1.3.2.2 Measurement of ROS 
 
The lack of valid techniques for ROS measurement may be one reason for the opposing 
results in investigations of their role in HPV [85]. Technical limitations of different fluorescent 
probes with regard to their specificity and autooxidation [86] have been the major drawbacks 
in the past. Also, artefacts due to a non-physiological environment of isolated arteries and 
PASMC have to be considered. For example, pretone may influence ROS production by 
activation of stretch-sensitive NAD(P)H oxidases [87] and some investigators believe that 
healthy mitochondria do not release ROS under baseline conditions at all [88]. Furthermore, 
most of the measurements do not take into account the possibility that the alterations of ROS 
occur localized in the cell and are dependent on O2 concentration and time course of the 
experiment [70]. This could even lead to opposite reactions of different ROS producing 
systems, the experimental setup pronouncing the one or the other [73]. 
 
Arguments for a decrease in ROS production are provided by studies in the isolated lung 
indicating a decrease of superoxide in hypoxia, but are limited in their validity by the use of 
luminol and lucigenin enhanced chemiluminescence [89], that is influenced by media 
conditions [90], edema of the lung [91] and induction of superoxide [92]. To overcome the 
limitations that are related to the use of one specific dye and localization of ROS production 
in the lung, measurements were performed in denuded pulmonary arterial rings with three 
different optical methods (Amplex Red, dichlorofluorescein (DCFH) and lucigenin) and 
confirmed the decrease of ROS during hypoxia [23].  
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In contrast, measurements in isolated pulmonary arteries with chemiluminescence and 
electron spin resonance transfer (ESR), a technique to overcome limitation of dye related 
detection methods, showed an increase of hydroxyl and alkyl radicals during hypoxia [93]. 
The same discrepancy occurs in measurements of PASMC [94-96]. Measurements with a 
new fluorescence resonance energy transfer (FRET) method and ESR support the theory of 
a localized, hypoxia-dependent ROS increase during HPV [84, 97-99].  An overview is 
provided by Sommer et al. [85]. 
 
Therefore, the apparently conflicting conclusions concerning ROS in HPV may be explained 
by the hypothesis that a local, subcellular and compartmentalized regulation of ROS triggers 
HPV, e.g. by localization of mitochondria close to Kv-channels [100]. 
 
1.1.3.3 Other mediators: ATP, AMP kinase, protein kinases, carbon monoxide (CO), 
hydrogen sulfide (H2S) 
It was early suggested that ATP acts a second messenger for HPV, as 1) inhibitors of the 
mitochondrial chain and of glycolysis caused pulmonary vasoconstriction and 2) oxidative 
phosphorylation is the main O2 consumption process [24, 101].  However, the role of ATP 
was again rejected, as changes in ATP content or deterioration of energy state during 
hypoxia could not be detected [102, 103], O2 affinity (p50) of cytochrome c oxidase seemed 
to be too high to enable ATP to be influenced by mild hypoxia [104] and inhibitors of the 
mitochondrial cytochrome c oxidase did induce pulmonary vasoconstriction, but did not 
abolish HPV [105], an effect, that was not consistently found by different investigations (see 
Table 1). 
 
Still there has also been evidence, that oxidative ATP production might be impaired and 
energy state is maintained by upregulation of glycolysis [106], especially in sustained HPV 
[102, 107]. A decrease in energy state was considered to be responsible for hypoxic 
relaxation, after an initial rise in vascular tone during hypoxia. In contrast to femoral arteries, 
pulmonary arteries recovered after that and constricted again. This was postulated to be due 
to accelerated glycolytic ATP production in pulmonary arteries [102].   
 
Small and/or localized changes in ATP production might act - beyond deterioration of energy 
state - as second messenger via activation of AMP activated protein kinase α1 (AMPK) by an 
increase of the AMP/ATP ratio. AMPK can elevate cADP-ribose that releases calcium 
through ryanodine-sensitive calcium stores. This effect is enhanced by additional increase of 
β-NADH/NAD+ relationship, that leads to inhibition of cADP-ribose-hydrolase and also 
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increases intracellular cADP-ribose [68, 108]. As ATP would be necessary for change of 
AMP/ATP relationship, but also for phosphorylation of AMPK during activation, low decrease 
of ATP was supposed to activate the AMPK-cADP-ribose pathway, whereas a high decrease 
would block the pathway again. This effect could possibly explain dose dependent results of 
studies with cyanide on HPV. However, inhibition of AMP kinase has been shown to 
preferentially inhibit sustained HPV [109]. Furthermore the importance of decrease ATP was 
challenged by the finding that oxidative stress and not an increase in the AMP/ATP ratio is 
required for hypoxic activation of AMPK [110]. 
Besides AMP kinase, several other protein kinases have been suggested as modulators of 
HPV [111]. Especially PKC via activation of NADPH oxidase [112] might be involved. PKC 
activation might be induced by mitochondrial ROS production [113]. The recently suggested 
second messenger diacylglycerol (DAG) that regulates TRP6 channel activity [58] might be 
increased by ROS activated phosopholipase C or mitochondrial DAG production [114]. Also 
inhibition of mitochondrial beta-oxidation might increase DAG concentrations due to 
increased acetyl-CoA concentration which is converted to DAG via glycerol-3-phosphate. 
 
As CO has been shown to inhibit HPV, a role for cytochrome P450 dependent 
hydroxyeicosatetraenoic acid (HETE) production and a pathway depending on heme 
oxygenase and large-conductance calcium- and voltage-activated potassium channels 
(BKCa) had been proposed. This will be discussed below.  
Recently, decreased mitochondrial H2S oxidation during hypoxia has been speculated to be 
the O2 sensing mechanism of HPV [115]. 
. 
1.1.3.4 Oxygen sensors in HPV - location and dynamic range 
For the triggering mechanism of HPV, two main requirements are necessary: 1) the sensor 
has to respond to changes in O2 with a sensitivity in the range of mild hypoxia and 2) the 
sensor has to be able to utilize the above mentioned mediators for signaling to the effector 
pathways. This emphasizes the problem of defining hypoxia. HPV in the isolated lung 
exhibits a sigmoidal stimulus-response relationship with an onset at 7-10% O2  (~ pO2 50-75 
mmHg) and half-maximal response at 3-7% O2 (~ pO2 25-50 mmHg) [5, 7]. Isolated cells 
were shown to contract in response to O2 concentrations of 3-7% O2  (~ pO2 20-50 mmHg) 
[21, 22], whereas studies with measurement of intracellular calcium were usually performed 
at pO2 levels below 4% O2 (pO2 30 mmHg) [40, 105, 116]. Therefore, it is clear that a sensor 
must exhibit sensitivity to at least 7% O2 (~ pO2 50 mmHg) and below. Although HPV might 
depend on priming factors, the primary O2 sensor is obviously located in the PASMC 
themselves as 1) isolated PASMC contract in response to hypoxia and 2) increase their 
intracellular calcium.  
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1.1.3.4.1 Mitochondria as oxygen sensor: ATP production – ROS metabolism – 
calcium buffering 
 
Mitochondria, as the primary O2-consuming organelle of the cell, have long been thought to 
play a key role in the O2 sensing process of HPV, for two main experimental reasons: First, 
inhibitors of the mitochondrial chain block specifically HPV in isolated lungs and pulmonary 
arteries, secondly PASMC depleted of mitochondria do not show hypoxia specific reactions 
[105]. In general, mitochondria have diverse functions in the cell. They produce energy, 
control calcium homeostasis of the cell and act as a source and scavenger of ROS. Energy 
is produced by reducing NADH and flavin adenine dinucleotide (FADH) and building up a 
proton gradient across the inner mitochondrial membrane, which is used for ATP synthesis 
by shuttling back protons through the mitochondrial ATP-Synthase (complex V). The energy 
for the proton gradient is provided by electrons being passed along a system of redox 
enzymes with increasing redox potential (=increasing electron affinity), the electron transport 
system, finally reducing O2 to water (see Figure 1.3 and 1.4). Members of the electron 
transport system are complex I and II providing electrons, complex III passing on electrons 
via cytochrome c, and complex IV including the final reduction centre of O2. The 
electrochemical gradient is also used to drive other membrane-embedded ion or protein 
exchangers, like the calcium uniporter. Electron transfer onto O2 not occurring in complex IV 
can result in incomplete reduction of O2 and production of ROS. Cellular calcium 
concentration can be influenced directly by buffering of cytosolic calcium or indirectly via 
regulation of capacitative calcium entry. In summary, mitochondria could trigger or modulate 
HPV via hypoxic inhibition of complex IV, disturbed ROS metabolism or change in calcium 
handling (see Figure 1.3).  
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Figure  1.3 Possible role of mitochondria in oxygen sensing of HPV 
Hypoxia can interfere with mitochondrial metabolism by 1a) inhibition of oxidative phosphorylation, 1b) 
change in mitochondrial redox state, 2) superoxide production or 3) calcium homeostasis. 
ANT: adenine nucleotide translocase, ADP: adenosine diphosphate, ATP: adenosine triphosphate, 
Ca2+: calcium, Ca2+-channels: mitochondrial calcium channels (mitochondrial calcium uniporter, 
mitochondrial ryanodine receptor, permeability transition pore, sodium- and proton exchanger), CCE: 
capacitative calcium entry, ER: endoplasmatic reticulum, ETS: Electron transport system, IMAC: inner 
membrane ion channel, NADH: reduced nicotinamide adenine dinucleotide, O2-: superoxide, VDAC: 
voltage dependent anion channel, ∆ψmito: mitochondrial membrane potential.  
 
1.1.3.4.1.1 Inhibition of complex IV 
 
Inhibition of complex IV as a mechanism for HPV was early suggested, as inhibitors of the 
mitochondrial chain mimicked the effects of hypoxia in the pulmonary vasculature and 
inhibited HPV [24, 101]. However, the mechanism by which mitochondria elicit HPV was 
soon discussed to be beyond simple inhibition of complex IV, as 1) complex IV and 
mitochondria of isolated non-pulmonary cells are largely functional at very low O2 
concentrations (= have high O2 affinity) [117], but HPV occurs at mild hypoxia and 2) 
application of inhibitors of complex IV suggested the O2 sensing mechanism to be upstream 
of complex IV [84, 118, 119].  
As already discussed above, in line with this, no ATP depletion [103, 120] was evident in the 
whole lung during hypoxia, although this might be due to a shift from oxidative 
phosphorylation to glycolytic ATP production [106]. However, slight inhibition of complex IV 
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that regulates ROS production, calcium signaling, NADH concentration or AMP/ATP ratio 
[108] could act as a signal for HPV beyond ATP depletion. 
This might be supported by a lower O2 affinity of mitochondria in PASMC compared to other 
cell types or by modulation of affinity by NO or CO, so that mitochondria of PASMC are 
inhibited at mild hypoxia. Neither O2 affinity of PASMC nor O2 affinity in the isolated lung has 
been investigated before. A hint for a certain degree of inhibition of the mitochondrial 
respiratory chain during hypoxia is the high NADH/NAD+ ratio during acute hypoxia (2% O2, 
pO2 15-18 mmHg) [107], but not NADPH/NADP+ ratio (5-8% O2, pO2 35-60 mmHg) [121] in 
isolated pulmonary arteries.  
Despite this consideration, the failure of the complex IV inhibitor cyanide to inhibit HPV in 
some investigations (see Table 1) questioned the general importance of hypoxic inhibition of 
complex IV. However, in most investigations cyanide mimicked hypoxic effects and at least in 
isolated lung experiments inhibitory effects on HPV seem to be dose-dependent (Table 1). 
 
 ROS Normoxic effect HPV/hypoxia induced 
cellular effects 
Model 
Cyanide , inhibited 
by SOD 
 tone, inhibited 
by SOD 
-- 0.15µM-1.5µM,  buffer 
perfused rat lung, 
PASMC [96] 
   tone, inhibited 
by ebselen and 
myxothiazol 
 10 µM, buffer perfused 
rat lung [95] 
   tone inhibited: 25 µM 
specifically, 80 µM 
unspecifically 
25-80µM, buffer 
perfused rabbit lung 
[122] 
   tone inhibited, unspecifically 1 mM, buffer and blood 
perfused rat lung [123] 
 -- during 
hypoxia 
  [Ca2+]i 1 µM, PASMC [84] 
  -- no effect on phase 1, 
potentiates phase 2 
100 µM, PA [107] 
   [Ca2+]i, also in 
non-PASMC 
not investigated 10 mM, PASMC [124] 
Azide   tone inhibited, unspecifically isolated rat lung [123] 
 --  inhibited, unspecifically vessel wall  [125, 136] 
 
Table 1: Effect of cyanide and azide (inhibitors of complex IV) on HPV 
[Ca2+]i: intracellular calcium, SOD: superoxide dismutase, PA: pulmonary artery, PASMC: pulmonary 
arterial smooth muscle cells, specifically: HPV was inhibited, unspecifically: HPV and vasoconstriction 
induced by a vasoconstrictive substance was inhibited 
 
1.1.3.4.1.2 Mitochondrial ROS production 
 
Due to above mentioned high O2 affinity of mitochondria, ATP maintenance during hypoxia, 
conflicting results regarding complex IV blockade and generally accepted importance of ROS 
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in O2 sensing, studies focused on an O2 sensing mechanism via mitochondrial ROS 
production independent of complex IV.  
Mitochondria are known to produce ROS as by-products during electron transfer at complex 
I, II or III. Single electrons are passed on to O2, producing a superoxide radical, which is 
detoxified by mitochondrial SODs located in the mitochondrial matrix and intermembrane 
space. The resulting H2O2 can readily diffuse through membrane into the cell, but also 
superoxide can diffuse through an inner membrane ion channel (IMAC) and a voltage 
dependent anion channel (VDAC) located in the matrix and intermembrane space, 
respectively [126, 127].  
 
However, there is currently much discussion about whether mitochondrial ROS release is 
increased or decreased during hypoxia to trigger HPV [14]. A decrease in ROS production at 
complex I or III can be caused by a lack of O2 as substrate due to decreased pO2. ROS 
production at complex I is inhibited by a decreased NADH/NAD+ ratio, reduced/oxidized 
ubiquinone (QH2/Q) ratio or a decreased mitochondrial membrane potential [128]. 
Increased ROS production is favored by high membrane potential with concomitantly slowed 
down distal electron flow and a highly reduced ubiquinone (= high ubiquinol) pool. This is the 
case in so called "state 4" respiration characterized by inhibition of complex V due to high 
ADP/ATP ratio [128, 129].  A similar condition which might result in high ROS production is 
the combination of high electron inflow (high NADH concentration) and inhibition of complex 
IV as occurring during ischemia or NO mediated inhibition of cytochrome c oxidase [128, 
130, 131]. The latter condition supports ROS production by high membrane potential, 
probably caused by reverse function of complex V due to high glycolytic ATP production 
[130]. However, the contribution of complex I or III to ROS production under these conditions 
is under debate, but believed to be relatively low for complex III [128, 132]. Discrepant results 
may be caused by interference of ROS production with ROS detoxifying systems, allowing 
mitochondrial matrix ROS produced by complex I or quinone reductase (Qi) site of complex 
III to be eliminated very fast in intact mitochondria [133]. Therefore, in intact mitochondria the 
quinol oxidase (Qo) site of complex III might be the dominant site of ROS production, 
because it releases ROS into the intermembrane space, away from the antioxidant defense 
of the matrix [133]. This process can be provoked by inhibition of complex III downstream of 
the Qo site of semiubiquinone by antimycin A hereby increasing life time of semiubiquinone. 
In contrast, further downstream inhibition of complex IV is believed to lead to ROS production 
at complex I, but not ROS production of complex III, as reduced cytochrome c1 cannot dock 
to the iron-sulfur cluster and thus prevents electron entry into complex III [133]. Therefore 
inhibition of complex IV seems to require additional mechanism to induce ROS production at 
complex III. Additional damage of the Qo site and iron-sulfur protein, e.g. by ischemia, has 
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been suggested to result in increased electron leak at this site [133], but also unspecific 
interference of O2 with the mitochondrial membrane during hypoxia [134]. However, intrinsic 
hypoxic ROS production of mitochondria was questioned and additional cellular factors, like 
regulation of SOD activity or redox state of mitochondrial cytochromes by NO were 
suggested to be a prerequisite for increased ROS production at complex III [128, 135]. Other 
sites of hypoxic ROS production might include complex II [136], glycerol-1-phosphate 
dehydrogenase, and dihydroorotate dehydrogenase [129]. Generally ROS can also be 
increased by mitochondrial calcium influx [137] or activation of mitochondrial potassium 
channels [138]. However, also release of ROS, e.g. via membrane potential dependent 
VDACs could act as a mechanism for ROS regulation in hypoxia (see Figure 1.4) [126]. 
 
 
 
Figure  1.4 Mechanisms of mitochondrial ROS production 
For details see text. 
ADP: adenosine diphosphate, ATP: adenosine triphosphate, Ca2+: calcium, Cu/Zn-SOD: copper-zinc 
superoxide dismutase, e-: electron, Fe2S2: iron sulfur cluster, IMAC: inner membrane ion channel, K-
channel: potassium channel, Mn-SOD: manganese superoxide dismutase, NADH/NAD+: 
reduced/oxidized nicotinamide adenine dinucleotide, O2-: superoxide, Q-o: semiubiquinone at the 
quinol oxidase site, Q-i: semiubiquinone at the quinone reductase site, QH2/Q: reduced/oxidized 
ubiquinone, ROS: reactive oxygen species, VDAC: voltage dependent anion channel, I/II/III/IV: 
complex I/II/III/IV, bh/bl/c1/aa3: cytochrome bh/bl/c1/aa3 with absorption peaks in nm in brackets. 
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For an involvement of mitochondrial ROS in HPV, the original redox hypothesis was 
proposed by Weir, Archer and colleagues assuming a decrease in the production of 
mitochondrial ROS, resulting in the inhibition of Kv channels mediated by redox couples like 
GSH/GSSH, NADH/NAD+ [96, 139]. In contrast, Schumacker, Chandel and co-workers 
suggested that an increase in ROS production during hypoxia from the semiubiquinone 
binding site in mitochondrial complex III triggers subsequent intracellular calcium release and 
thus HPV [74, 95]. Main discrepancies emerge due to different results regarding the effects 
of mitochondrial inhibitors on normoxic or hypoxic vessel tone and regarding measurement of 
ROS (see Table 2). In Archer´s studies rotenone inhibited HPV or Kv channel activity, 
decreased ROS and increased the normoxic tone. As antimycin A led to similar reactions, 
whereas cyanide did not inhibit HPV, Archer concluded that a decrease in ROS at Complex I 
or III triggers HPV. In contrast, Schumacker did not find a specific attenuation of the hypoxia-
induced calcium increase and HPV by antimycin, but an inhibition of HPV and decrease of 
ROS with myxothiazol. His group therefore concluded that an increase of ROS at complex III 
induced HPV. The effects of the inhibitors seem to depend on several variables, like 
respiration substrate, inhibitor concentration or pre-blockade by mitochondrial inhibitors.  
Generally the results generated with antimycin and myxothiazol have to be judged critically, 
as both substances seem to inhibit HPV by interaction with the NO system, which is not 
thought to be involved in O2 sensing (see Table 2). A more convincing approach recently 
showed by using cytochrome b depleted cells, that mitochondrial ROS production at complex 
III is necessary for hypoxic hypoxia-inducible factor (HIF) stabilization [140]. 
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 ROS  Normoxic 
tone 
HPV Model 
Rote-
none 
  inhibited isolated lung/PASMC, bolus 
of 1µM/0.1µM [96]  
    inhibited PA/PASMC, 5µM, opposite 
in renal tissue [23] 
   inhibited, unspecifically isolated lung, 0.5 µM [123] 
     vessel wall, 10µM [136]  
   inhibited, specifically  isolated rat lungs/PASMC, 
~0.1 µM (50ng/ml) [95]  
  -- with 
inhibited 
NO 
inhibited, specificity 
pronounced under blocked 
NO 
isolated rabbit lung, 30-350 
nM [118] 
  -- inhibited PA, 100 nM [107] 
3-NPA prevents 
hypoxia- 
induced 
increase 
 inhibited Intraacinar arteries [125, 
136] 
  -- inhibited isolated lung [118] 
Suc-
cinate 
 -- reverses effect of rotenone PA [107] 
Anti-
mycin 
A 
 in normoxia 
and hypoxia 
 inhibited, unspecifically whole lung/PASMC [96], 
bolus of 5µM/0.1 µM 
   inhibited PA/PASMC, 50µM, 
opposite in renal tissue [23] 
   inhibited, unspecifically isolated rat lung, 5-10µM 
[123] 
   inhibited unspecifically at 
10ng/ml, no change at 1 
ng/ml 
isolated lung, ~ 20 nM/2 nM 
(10ng/ml/1 ng/ml) [95] 
  in normoxia 
and hypoxia 
 pronounced vasodilation  vessel wall, ~ 6 µM (3 
µg/ml) [125, 136]  
  -- with 
inhibited 
NO 
inhibited unspecifically 
under blocked NO  
isolated lung, 1-4 nM [118] 
HQNO   inhibited specifically isolated lung [118] 
Myxo-
thiazol 
 during 
hypoxia 
 decreased [Ca2+]i during 
hypoxia 
PASMC, 100 nM [84] 
  during 
hypoxia 
-- inhibited isolated rat lungs/PASMC, 
50 ng/ml, ~0.1 µM [95] 
  -- inhibited PA, 100 nM [107] 
  -- with 
inhibited 
NO 
HPV inhibited 
unspecifically, especially 
under preblocked NO 
isolated lung, 50-80 nM 
[118] 
 
Table 2: Mitochondrial inhibitors and HPV 
rotenone: inhibitor of complex I, 3-NPA (3-nitropropionic acid): inhibitor of complex II, succinate: 
substrate of complex II, antimycin A/HQNO (2-n-heptyl-4-hydroxyquinoline-N-oxide): inhibitor of Qi site 
of complex III,  myxothiazol: inhibitor of Qo site of complex III, PA: pulmonary artery, PASMC: 
pulmonary arterial smooth muscle cell, [Ca2+]i: intracellular calcium, NO: nitric oxide, specifically: HPV 
was inhibited, unspecifically: HPV and vasoconstriction induced by a vasoconstrictive substance was 
inhibited. 
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1.1.3.4.1.3 Calcium homeostasis  
 
Calcium homeostasis of the cell is balanced by mitochondria, that buffer calcium [141-143] 
and regulate capacitative calcium entry [144]. They take up calcium via a calcium uniporter, 
that is driven by mitochondrial membrane potential and the concentration of cytosolic calcium 
[137]. It was suggested, that inhibition of mitochondrial calcium uptake by p-trifluoromethoxy 
carbonyl cyanide phenyl hydrazone (FCCP) or hypoxia augmented intracellular calcium 
increase [144], which fits to the observation that mitochondrial uncouplers increase normoxic 
tone and enhance HPV in isolated lungs [118]. 
 
1.1.3.4.2 NAD(P)H oxidase 
 
In vascular smooth muscle cells, NAD(P)H-dependent ROS production occurs mainly 
intracellularly [145] and has been proposed to be the main ROS producing system compared 
to other cellular systems, therefore probably playing a role in HPV [146]. The classical 
leukocyte NADPH oxidase is composed of the transmembrane subunits gp91 phox (now also 
termed NOX2) and p22, which include cytochrome b558, and the cytosolic subunits p47phox, 
p67phox and p40phox. In contrast to the leukocytic NADPH oxidase certain non-phagocytic 
NADPH oxidases, that substitute gp91 (NOX2) e.g. by the isoforms NOX1 and NOX4, 
produce low amounts of superoxide in the intracellular compartment not only after activation, 
but also constitutively [145, 147].  
Leukocytic NADPH oxidase superoxide production was shown to be dependent on pO2, with 
a slow decrease of ROS release with decreasing pO2 and a sharp decline at an O2 
concentration lower than 1% (pO2 8 mmHg) [148]. However, its activity also depends on 
cellular membrane potential and the NADPH concentration [149, 150]. Activation can be 
induced by phosphorylation, which may involve phospholipase A2 and PKC [112, 151]. 
 
Marshall and colleagues first described a NAD(P)H oxidase in PAs, that had an unusually 
low redox potential and might play a role in HPV. Isolated PASMC demonstrated an increase 
in superoxide production under hypoxic conditions, which was suggested to be derived from 
that NAD(P)H oxidase [152]. Several subsequent studies showed inhibition of HPV by 
inhibitors of the NAD(P)H oxidase, which were partially limited by specificity of the inhibitors, 
like diphenyliodonium (DPI), which also inhibits mitochondrial enzymes [153-156] or  
apocynin, which seems to be a ROS scavenger in general. More specificity was proposed for 
4-(2-aminoethyl)benzenesulfonyl fluoride, which selectively inhibited HPV in isolated rabbit 
lungs [154] and cadmium sulphate which inhibited HPV in isolated pulmonary arteries [157].  
However, the role of NADPH oxidases in O2 sensing then seemed to become negligible due 
to a study that demonstrated that gp91phox-deficent mice fully exhibit HPV [158]. Although 
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this clearly excludes the phagocytic NADPH oxidase type to be the O2 sensor in HPV, it was 
demonstrated that mice deficient of the cytosolic NADPH oxidase subunit p47 had a ~25% 
reduced acute, but unchanged sustained HPV [122]. Therefore isoforms of the leukocytic 
NADPH oxidase may, at least in part, function as O2 sensors in HPV. 
 
Whereas some investigations proposed decreased ROS production by NADPH oxidases 
during HPV [159], others supported the initial hypothesis of increased ROS production during 
hypoxia by an activation of a NADPH oxidases, as all the inhibitors of NADPH oxidases 
inhibited, but did not mimic HPV [81]. In isolated perfused lungs, intravascular NADPH 
oxidase dependent superoxide concentration increased during graded hypoxia peaking at 
5% O2 (pO2 38 mmHg), when NADPH oxidase was maximally stimulated with phorbol 
myristate acetate (PMA), although under non-stimulated conditions superoxide release 
decreased with hypoxia. Therefore it was concluded that regulation of electron flux rather 
than O2 may be the rate-limiting step in superoxide formation from non phagocytic NADPH 
oxidase [97]. NADPH oxidases might be activated in HPV by PKC [112] or phospholipase A2 
[151, 160].  
 
1.1.3.4.3 Cytochrome P450, EETs and HETEs 
 
Cytochrome P450 monooxygenases (P450 hypdroxylase [CYP4A] and P450 epoxygenase 
[CYP2C]) that produce 19- and 20-hydroxyeicosatetraenoic acids (HETEs) and 
epoxyeicosatrienoic acids (EETs) by oxidizing arachidonic acid (AA) have been postulated to 
play a specific role in HPV [161]. 20-HETEs dilated isolated pulmonary arteries of the human 
[162] and rabbit pulmonary artery rings [163]. In contrast they constricted kidney, brain and 
striate muscle vessels [164]. EETs decreased tone of isolated lungs of the rabbit [165] and 
the dog [166], but also have been shown to constrict pulmonary vessels [167].  
Because of their heme moiety the activity of cytochrome P450 enzymes is highly O2 
dependent and hypoxia could block conversion of AAs into 20-HETE and EETs with 
subsequent decrease of vasodilatory prostanoids. Administration of inhibitors of CYP4A 
showed normoxic vasoconstriction and subsequent increase of HPV [163]. Inhibition of 
Cytochrome P-450 also reversibly inhibited potassium currents and depolarized PA cells 
[168]. In contrast, increasing the concentration of EETs by inhibition of soluble epoxide 
hydrolase (sEH) inhibitors or use of sEH knock-out mice enhanced HPV and caused 
normoxic vasoconstriction by a mechanism dependent on transient receptor potential 6 
(TRP6) signaling [169]. 
However, the specificity for blockade of HPV can be questioned [170], as well as the 
necessity for an intact P450 system for HPV, as the specific inhibitor 1-aminobenztriazole 
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attenuated HPV, but during following washout the activity of P450, but not the strength of 
HPV is still decreased [171]. Recently inhibition of CYP2C29, has been shown to decrease, 
but not abolish HPV [172]. 
Cytochrome P450 can be identified by characteristic carbon monoxide spectrum (see 
appendix) or spectral alterations due to substrate binding [173]. 
1.1.3.4.4 Hemeprotein related to potassium channels 
 
A common physiologic mechanism to detect O2, NO and CO for signal transduction is the 
use of a great variety of heme-based proteins, that respond to a wide range of O2 
concentrations [174]. Besides the already discussed ones, that are cytochromes of the 
respiratory chain and the NADPH-oxidase, it was recently suggested, that heme oxygenase-
2 (HO-2) might play a role in O2 sensing via cytochrome P450 reductase dependent 
production of CO [175]. A large conductance calcium and voltage dependent potassium 
channel (BKCa) is co-localized with HO-2 and activated by HO-2 produced CO during 
normoxia [176]. Hypoxia therefore could inhibit HO-2, decrease CO and lead to 
vasoconstriction. However, recently this concept has been challenged by an investigation 
showing that mice deficient of the gene for HO-2 and BKCa have no limitation of HPV [177]. 
 
CO is well known to specifically inhibit HPV in isolated lungs [178], but it has a wide 
spectrum of interaction partners. It also may modulate hypoxic reactions by binding to 
cytochrome P450 (see above), mitochondrial cytochrome c oxidase [179] and activation of 
sGC [180]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  1.5 Heme oxygenase and carbon monoxide in oxygen sensing 
In the presence of O2 heme oxygenase-2 (HO-2) uses electrons from heme and NADPH-cytochrome 
P450 reductase to produce carbon monoxide (CO), which maintains opening of large conductance 
calcium and voltage dependent potassium channel (BKCa). Cytochrome P450 enzymes also use 
electrons from NADPH-cytochrome P450 reductase to produce hydroxyyeicosatetraenoic acids 
(HETE), epoxyeicosatrienoic acids (EET) and possibly superoxide (O2-) in the presence of O2. CO 
interferes with BKCa-channel, but also cytochrome P450, soluble guanylate cyclase (sGC) and 
cytochrome c oxidase of mitochondria. 
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1.2 Measurement of mitochondrial function in HPV 
Mitochondrial respiratory chain activity is dependent on substrate supply, activity of single 
mitochondrial chain enzymes, O2 concentration and ADP concentration. Under physiological 
conditions, ADP concentration is of major importance for regulation of respiration in order to 
adjust cellular ATP production to demand. Therefore, maximal respiration can be achieved in 
isolated mitochondria with maximal ADP concentration, which is the so called "state 3" 
respiration, in contrast to "state 4" respiration under conditions of ADP depletion [181, 182]. 
However, fine-tuning mitochondrial respiration can be achieved by mitochondrial calcium 
concentration and metabolites controlling complex IV activity (e.g. NO, CO, ATP) [137, 183]. 
Mitochondrial respiratory chain activity can be directly monitored by either measurement of 
mitochondrial O2 consumption (i.e.mitochondrial respiration), or under hypoxia and specific 
inhibitors by measurement of cytochrome redox state [117, 184, 185]. Indirect parameters for 
its activity can be mitochondrial membrane potential or ATP production [181, 182]. However, 
both of these parameters are also dependent on other factors, like mitochondrial proton leak 
and glycolytic ATP production. As direct measurement of mitochondrial respiratory chain 
function O2 consumption (i.e. respiration) and redox state are therefore most suitable. Both 
parameters can be determined isolated cells, whereas redox measurements can also be 
performed in isolated organs. Measurements in isolated lungs offer the advantage, that 
mitochondrial function can be directly compared to the strength of HPV. Furthermore the 
influence of other cell types surrounding PASMC and the O2 gradient from alveoli to 
mitochondria of PASMC can be taken into account. Isolated PASMC on the other hand, may 
be more specific for the O2 response, as they represent the O2 sensor cell type. Isolated 
PASMC should be preferred to isolated mitochondria, as they represent better physiological 
conditions without the need of artificial application of external substrate and ADP.  
 
1.2.1 Respiration 
Mitochondrial O2 consumption (= respiration) can be determined by measurement of the rate 
of decreasing O2 concentration in a closed chamber. O2 consumption in relation to O2 
concentration is a measure for O2 affinity of the mitochondria, usually expressed as O2 
concentration at half maximal O2 consumption (= p50 value). O2 concentration can be 
measured with pO2-electrodes based on different methodological background. However, the 
measurement technique is limited by 1) precision of the pO2 electrode, particularly in the low 
O2 range, 2) O2 consumption and backdiffusion of the surrounding material of the chamber 
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and 3) artefacts due to non-mitochondrial O2 consumption, resulting in a  biphasic O2 kinetics 
during mild hypoxia [186]. 
Furthermore, in whole organs mitochondrial O2 consumption cannot be determined.  
1.2.2 Redox state of mitochondrial cytochromes 
If electron transfer of the mitochondrial respiratory enzymes to O2 is limited by hypoxia, 
cytochrome aa3 of complex IV, and subsequently cytochrome c and cytochrome bl/h located 
in complex III will become reduced, which can be detected by a change in absorption 
characteristics (= difference spectrum, see methods Figure 2.4). Thus inhibition of 
mitochondrial respiration by hypoxia will be reflected by reduction of mitochondrial 
cytochromes, specifically cytochrome aa3, which can be detected in tissue or isolated cells 
by remission spectrophotometry (see methods 2.2.3.1). Moreover, measurement of the redox 
state of cytochrome bl/h can provide insight into mechanisms of ROS production at complex 
III. An increased electron transfer to produce superoxide could be reflected by an increased 
oxidation state of this cytochrome.  
An overview of mitochondrial and non-mitochondrial cytochromes is given in table 3. 
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1.3 Measurement of NADPH oxidase, cytochrome P 450 and 
other hemeproteins in HPV 
Besides mitochondrial cytochromes, also non-mitochondrial cytochromes can be observed 
by remission spectrophotometry, depending on their concentration and strength of absorption 
(absorption coefficient). 
 
Cytochrome Source Absorption peaks Inhibitors 
cytochrome aa3 complex IV of 
ETS 
reduced minus oxidized: 445/420/605 
nm [181] (see appendix) 
cyanide, 
azide, CO, NO
cytochrome b hemoglobin HbCO minus HbO2: 423/525/565 nm  
HbCO minus HbN2: 420/533/570 nm  
HbN2 minus HbO2: 435/560/592 nm 
(presented study) 
 
 myoglobin MbO2: 582, 544 [187] 
MbCO minus MbO2: 421/540/580nm 
[188] 
 
 sGC sGC-O2 minus sGC-N2: 437 nm [189] 
sGC-CO: 423/541/567 nm [190] 
 
 complex II reduced minus oxidized: 560 nm [191]  
 complex III of 
ETS 
anoxia minus normoxia: 
cyt. bh 430/532/562 nm 
cyt. bl: 430/532/566 nm (see appendix) 
[181, 192] 
antimycin A, 
myxothiazol, 
HQNO 
 NADPH oxidase reduced minus oxidized: 
cyt. b558: 425-427/558 nm [193, 194] 
SDT 
 cytochrome 
P450 
P450-CO minus P450-SDT: 450 nm 
[195] 
CO 
cytochrome c 
 
soluble protein 
of ETS 
reduced minus oxidized: 416/521/550 
nm [181] (see appendix) 
 
cytochrome c1 
 
complex III reduced minus oxidized: 418/520/553 
nm [181] 
 
 
Table 3: Cytochromes in mammalian tissue 
CO: carbon monoxide, ETS: electron transport system, Hb: hemoglobin, HQNO: 2-n-heptyl-4-
hydroxyquinoline-N-oxide, Mb: myoglobin, NADPH: nicotinamide adenine dinucleotide phosphate, N2: 
nitrogen, NO: nitric oxide, O2: oxygen, SDT: sodium dithionite, sGC: soluble guanylate cyclase  
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1.4 Aim of the study 
Although the response of the pulmonary vasculature to acute hypoxia has been described 
long since, the O2 sensing mechanism still remains to be elucidated. 
 
In order to identify the role of mitochondria in O2 sensing of HPV, the aim of the present 
study was to examine, 
1) if complex IV can act as an O2 sensor of HPV. This question should be addressed by 
correlating O2 dependent mitochondrial respiratory chain function to the strength of HPV,  
a) in the isolated lung (measurement of mitochondrial cytochrome redox state by 
remission spectrophotometry), 
b) in isolated PASMC (measurement of respiration and redox state by combination of 
spectrophotometry and respirometry) 
2) if complex III can act as an O2 sensor of HPV. This question should be addressed by 
measurement of changes in the redox state of cytochrome bl/h that can be attributed to 
altered ROS production during HPV,   
3) if cytochromes of PASMC behave differently or similarly to those from the systemic 
circulation (aortic smooth muscle cells [ASMC] and renal smooth muscle cells [RASMC]), 
and 
4) if yet undescribed or non-mitochondrial cytochromes involved in O2 sensing can be 
identified. 
The aim of the study is summarized in figure 1.6. 
 
Until now these uncertainties have not been resolved due to methodological limitations. In 
isolated organs mitochondrial O2 affinity (i. e. pO2 dependent mitochondrial respiration) 
cannot be determined, and in isolated cells simple determination of O2 affinity by O2 
consumption measurements is hampered by artefacts due to non-mitochondrial O2 
consumption resulting in biphasic O2 kinetics during mild hypoxia [186].  
To overcome these limitations, in this work  
1) the technique of remission spectroscopy was adapted in order to examine the redox state 
of the mitochondrial respiratory system in intact lungs and in isolated PASMC, ASMC and 
RASMC,  
2) high-resolution respirometry was used in PASMC, ASMC and RASMC.  
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Figure  1.6 Aim of the study  
How does hypoxia influence the function of mitochondrial respiratory chain enzymes and non-
mitochondrial cytochromes and can this be related to hypoxia-induced reactions in the isolated lung 
and PASMC? 
ATP: adenosine triphosphate, CO: carbon monoxide, EET: epoxyeicosatrienoic acids, ER: 
endoplasmatic reticulum, NADH: reduced nicotinamide adenine dinucleotide, ROS: reactive oxygen 
species, TRPC: transient receptor potential channels.  
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2 Material and Methods 
2.1 Materials 
2.1.1 Animals 
Chinchilla bastard rabbits of either sex (2.5–3.2 kg body weight) and C57BL/6J mice (21 -30 
g body weight, Jackson Laboratory) were used for the investigations. All animal experiments 
were approved by the local Governmental Commission.  
 
2.1.2 Equipment 
For isolated lung experiments: 
Air tight tubings  Cole-Parmer Instruments Company 
(Vernon Hills, USA) 
Amplifier (Plugsy DBA 660)  Hugo Sachs Elektronik (March-
Hugstetten, Germany) 
BP 742 Fresenius Roller Pump, Pulsatile Flow  Fresenius (Bad Homburg, Germany) 
Cat-Rabbit Ventilator UV 6025  Hugo Sachs Elektronik (March-
Hugstetten, Germany) 
Chart recorder (Rikadenki R 50 Series)   Rikadenki Electronics (Freiburg, 
Germany) 
Force Transducer, Load Cell Hottinger Balowin Messtechnik 
(Darmstadt, Germany) 
Frigomix-U  Braun Melsungen AG (Melsungen, 
Deutschland) 
Gas mixing chamber (KM 60–3/6MESO)  WITT (Witten, Germany) 
Gas (normoxic gas mixture, N2, O2, CO2, CO) Air Liquide Deutschland GmbH, 
(Ludwigshafen, Deutschland) 
Glassware Glassblowing (University of Giessen, 
Germany) 
Oszillographic recorder Hugo Sachs Elektronik (March-
Hugstetten, Germany) 
Pressure transducers Combitrans  Braun Melsungen AG (Melsungen, 
Germany) 
Respirator research setup system:  Hugo Sachs Elektronik (March-  
Isolated Perfused Lung for Mouse Size 1, IL-1 Hugstetten, Germany) 
Threats      Coats GmbH (Kenzingen, Germany) 
 
For remission spectrophotometry:  
CytoSPEC II       LEA Medizintechnik (Giessen, Germany) 
LEA flat probe      LEA Medizintechnik (Giessen, Germany) 
LEA endoscopic probe    LEA Medizintechnik (Giessen, Germany) 
LEA O2k probe     LEA Medizintechnik (Giessen, Germany)
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For respirometry: 
Oxygraph-2k      OROBOROS (Innsbruck, Austria) 
Hamilton Syringes     OROBOROS (Innsbruck, Austria) 
 
For fluorescence measurements: 
Olympus BX50 WI      Olympus (Hamburg, Germany) 
IMAGO CMOS-Kamera    Till Photonics (Martinsried, Germany) 
Software TILLvisION      Till Photonics (Martinsried, Germany) 
Hypoxic chamber flow through system  Institute of Pharmacology (University of 
Marburg, Germany) 
Licox electrode  Oxford Optronics (Oxford, United 
Kingdom) 
 
For cell isolation, culture and staining: 
Cell culture incubator   Flow Laboratories (Meckenheim, 
Germany) 
Centrifuge Rotina     Hettich (Tuttlingen, Germany) 
Cover slips (24x50 mm)     Menzel-Gläser (Braunschweig, Germany) 
Falcon tubes  Greiner bio-one (Frickenhausen, 
Germany)  
Fluorescence microscope (Leica CTR MIC)  Leica (Wetzlar, Germany) 
Freezer -20 °C     Bosch (Stuttgart, Germany) 
Fridge +4°C      Bosch (Stuttgart, Germany) 
Glass bottles, 250, 500, 1000 ml   Fisher (Schwerte, Germany) 
Light microscope     Leica (Wetzlar, Germany) 
Magnet concentrator     Dynal A.S (Oslo, Norwegen) 
Pipetboy      Eppendorf (Hamburg, Germany) 
Tissue culture flask T75   Greiner Bio-One (Frickenhausen, 
Germany) 
15G cannula      Dispomed Witt (Gelnhausen, Germany) 
18G cannula      HMD Healthcare LTD. (Horsham, UK) 
8er permanox chamber slides   Nunc GmbH & Co. KG (Wiesbaden, 
Germany) 
 
 
2.1.3 Chemicals and reagents 
For isolated lung experiments: 
Aqua destillata.     Baxter S.A. (Lessines, Belgien) 
Krebs Henseleit buffer     Serag-Wiessner (Naila, Germany) 
Ketamine (Ketavet)     Pharmacia GmbH (Erlangen, Germany) 
Narcoren       Merial AG (Hallbergmoss, Germany)  
Natriumhydrogencarbonat (NaHCO3) 1 M 8.4%  Serag-Wiessner (Naila, Germany) 
Thromboxane analogon U-46619   Sigma-Aldrich (St. Louis, USA) 
Heparin      Roche (Basel, Switzerland) 
Xylazine (Rompun) 2%  Bayer Vital GmbH (Leverkusen, 
Germany) 
Xylocain 2%       AstraZeneca GmbH (Wedel, Germany) 
 
For spectrophotometry/respirometry: 
Antimycin A       Sigma-Aldrich (St. Louis, USA)
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Cytochrome c      Sigma-Aldrich (St. Louis, USA)  
Medium 199, colorless    Invitrogen (Carlsbad, USA) 
Potassium cyanide      Sigma-Aldrich (St. Louis, USA) 
Sodium dithionite (SDT)    Sigma-Aldrich (St. Louis, USA) 
 
For fluorescence measurements: 
5,5′,6,6′-tetrachloro-1,1′,3,3′-    Invitrogen (Carlsbad, USA) 
tetraethylbenzimidazolcarbocyanine iodide (JC-1)       
MitoSox        Invitrogen (Carlsbad, USA) 
Fura-2       Invitrogen (Carlsbad, USA) 
 
For cell isolation, culture and media: 
Albumin       Sigma-Aldrich (St. Louis, USA) 
Agarose with low melting point   Sigma-Aldrich (St. Louis, USA) 
Calcium chloride (CaCl2)    Merck (Darmstadt, Germany) 
Collagenase type IV      Sigma-Aldrich (St. Louis, USA) 
Dulbecco's Phosphate-Buffered Saline (DPBS) PAN Biotech (Aidenbach, Germany) 
Dimethyl sulfoxide (DMSO)    Sigma-Aldrich (St. Louis, USA) 
Dithiothreitol       Sigma-Aldrich (St. Louis, USA) 
Ethanol absolute     Riedel-de Haen (Seelze, Germany) 
Fetal calf serum (FCS)     PAA Laboratories (Cölbe, Germany) 
Glucose       Sigma-Aldrich (St. Louis, USA) 
Hyaluronidase      Sigma-Aldrich (St. Louis, USA) 
Iron oxide      Sigma-Aldrich (St. Louis, USA) 
Magnesium chloride (MgCl2 x 6 H2O)  Sigma-Aldrich (St. Louis, USA) 
Medium 199       Invitrogen (Carlsbad, USA) 
Papain       Worthington (St. Katharinen, Germany)  
Penicillin/Streptomycin (P/S)    PAN Biotech (Aidenbach, Germany) 
Potassium chloride (KCl)    Merck (Darmstadt, Germany) 
Sodium chloride (NaCl)    Roth (Karlsruhe, Germany) 
Trypsin/ ethylenediaminetetraacetic acid (EDTA) PAN Biotech (Aidenbach, Germany) 
2-(-4-2-hydroxyethyl)-    Merck (Darmstadt, Germany) 
piperazinyl-1-ethansulfonate (HEPES) 
 
For cell staining: 
Acetone       Sigma-Aldrich (St. Louis, USA) 
Collagen solution 0.01 % (collagen type I)  Sigma-Aldrich (St. Louis, USA) 
Bovine serum albumin 0.1 % (BSA)  PAA Laboratories GmbH (Pasching, 
Germany) 
Dako Fluorescent Mounting Medium   Dako cytomation (Hamburg, Germany) 
Methanol       Sigma-Aldrich (St. Louis, USA) 
Potassium dihydrogen phosphate (KH2PO4) Merck (Darmstadt, Germany) 
Sodium hydrogen phosphate (Na2HPO4 x 2H2O) Merck (Darmstadt, Germany),  
4',6-Diamidino-2-phenylindole (DAPI)  Sigma-Aldrich (St. Louis, USA) 
 
2.1.4 Antibodies 
anti-α-smooth muscle actin, Clone 1A4, monoclonal, mouse anti-human, Sigma-Aldrich, 
Steinheim, Germany 
anti-cytokeratin, Clone MNF116, monoclonal, mouse anti-human, Dako Cytomation, 
Hamburg, Germany 
anti-collagen I, rabbit anti-human, Alexa Fluor 488, Invitrogen, Karlsruhe, Germany
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anti-von Willebrand factor, rabbit anti-human, Dako Diagnostika, Hamburg, Germany 
antibody Alexa Fluor 488, goat anti-mouse IgG, Invitrogen, Karlsruhe, Germany 
antibody Alexa Fluor 488, goat anti-rabbit IgG, Invitrogen, Karlsruhe, Germany 
 
2.2 Methods 
2.2.1 Isolated lung models 
2.2.1.1 Isolated perfused and ventilated rabbit lung 
The model of isolated perfused rabbit lungs has been described previously [5]. Pathogen free 
male rabbits (body weight 2.8-3.8) were deeply anaesthetized with i.v. application of 
ketamine (30-50 mg/kg) and xylazine (6-10 mg/kg) and anticoagulated with heparin (1500 
U/kg body weight). The trachea was cannulated and animals were ventilated with room air 
(tidal volume 30 ml, frequency 30 strokes/min) by a rodent ventilator (Cat-Rabbit Ventilator). 
The lungs were excised under deep anesthesia while perfused via the pulmonary artery with 
Krebs Henseleit buffer (125.0 mmol/liter NaCl, 4.3 mmol/liter KCl, 1.1 mmol/liter KH2PO4, 2.4 
mmol/liter CaCl2, 1.3 mmol/liter MgCl2 and 275 mg glucose/100 ml); NaHCO3 was adjusted to 
result in a constant pH of 7.37–7.40. In parallel with the onset of artificial perfusion, 
ventilation was changed from room air to a normoxic gas mixture (5% CO2, 21% O2, 
balanced with N2). A positive end expiratory pressure of 2 cm H2O was chosen for prevention 
of regional alveolar collapse. After the lungs were rinsed for 45 min with 6 liter of buffer fluid 
for washout of the blood, the perfusion circuit was closed for recirculation by a peristaltic 
pump (BP 742 Fresenius Roller Pump) connected to arterial and venous parts of tubing 
cannula. The total system volume was 250 ml, the buffer flow rate was 150 ml/min, and left 
atrial pressure was set at 2.0 mmHg to ensure zone III condition throughout the lung at end-
expiration. Because the perfusion rate is constant, changes in pulmonary artery pressure 
directly reflect changes in the pulmonary vascular resistance. The isolated lungs were freely 
suspended from a force transducer for continuous monitoring of organ weight. The entire 
system was heated to 38.5 °C. Pressures in the pulmonary artery, the left atrium, and the 
trachea were continuously registered. For hypoxic maneuvers, a gas mixing chamber (KM 
60–3/6MESO) was employed for step-wise changes in the ventilator O2 content.  
The lungs included in the study were those that 1) had a homogeneous white appearance 
with no signs of hemostasis, edema, or atelectasis; 2) revealed a constant mean PAP and 
peak ventilation pressure in the normal range; and 3) were isogravimetric during an initial 
steady state period of at least 20 min. 
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2.2.1.2 Isolated perfused and ventilated mouse lung 
Changes in pulmonary perfusion pressure were assessed in the isolated buffer-perfused 
mouse lung similar to the rabbit lung, as described. Briefly, mice were anesthetized with 
intraperitoneal (i.p.) injection of 80 mg/kg pentobarbital and anticoagulated with 1000 U/kg 
heparin. Catheters were inserted into the pulmonary artery and left atrium, and buffer 
perfusion via the pulmonary artery was initiated at a flow of 0.2 ml/min. Ventilation was then 
changed from room air to a premixed gas (21% O2, 5% CO2, balanced with N2), left atrial 
pressure was set to 2.0 mmHg, and flow was slowly increased from 0.2 to 2 ml/min. Positive 
pressure ventilation was performed with a tidal volume of 250 µl, 90 breaths/min, and 2 cm 
H2O positive end-expiratory pressure. For hypoxic maneuvers, a gas mixing chamber (KM 
60–3/6MESO) was employed for step-wise changes in the ventilator O2 content. Ten-minute 
periods of hypoxic ventilation were alternated with 15 min of normoxia. Gas mixtures 
contained carbon monoxide were premixed and applied via an air tight vessel. 
For perfusion Krebs-Henseleit buffer, containing 120 mmol/liter NaCl, 4.3 mmol/liter KCl, 1.1 
mmol/liter KH2PO4, 2.4 mmol/liter CaCl2, 1.3 mmol/liter MgCl2, and 13.32 mmol/liter glucose 
as well as 5% (wt/vol) hydroxyethylamylopectin (molecular weight 200,000) was employed. 
The total system volume was 15 ml.  
 
2.2.2 Isolated cell experiments 
2.2.2.1 Isolation of pulmonary and renal arterial smooth muscle cells 
Smooth muscle cells were isolated from pulmonary precapillary arteries and cultured as 
described previously [58, 196, 197].  The pulmonary artery of rabbit lungs was cannulated as 
described for isolated lung experiments. Lungs were slowly washed with 50 ml DPBS via a 
syringe. Afterwards lungs were perfused with 50 ml iron containing medium (medium 199, 
1% P/S, 0.5% agarose with low melting point, 0.5% iron oxide particles, 40°C). Iron particles 
got fixed in the precapillary vessels [197] and homogenous distribution was controlled 
visually. Afterwards lung tissue was fixed by tracheal infusion of medium 199, with 1% P/S 
and 1% agarose at 40°C. Lungs were removed and put in ice-cold DPBS for hardening of 
agarose. A similar isolation procedure was used for renal precapillary arteries. After 
cannulation of the renal artery, kidneys were washed and perfused with iron containing 
medium as described above. 
Afterwards lungs or kidneys were cut with scissors for 15 minutes to very small pieces and 
solved in 30-35 ml DPBS per falcon tube. Iron loaded tissue pieces were collected by 
external application of a magnet to the falcon tubes. Supernatant consisting of buffer and non 
iron loaded tissue was removed by suction. Iron loaded tissue was washed by this procedure 
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three times. Afterwards tissue pieces were incubated at 37°C for 55 minutes with 80 U/ml 
collagenase type IV (dissolved in medium 199 und 1% P/S) for removal of fibroblasts, and 
subsequently pulled several times through a 15G cannula and 18G cannular for dissection. 
Iron containing tissue pieces were washed again three times with medium 199 (containing 
1% P/S and 10% FCS) according to the procedure described above including the use of a 
magnet. Tissue pieces were transferred in T75 flasks for culture.  
 
2.2.2.2 Isolation of aortal smooth muscle cells 
The ASMC were dissected from isolated rabbit aortas after removal of the endothelial and 
adventitial cell layer. For this procedure isolated aortas were transferred into an isolating 
solution (127.0 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2 x 6 H2O, 11.8 mM glucose, 10.0 mM 
HEPES, 2.4 mM CaCl2), adventitia was removed manually, the aorta cut open longitudinally 
and washed in calcium free isolating solution. Afterwards aortal tissue pieces were first 
incubated in 5 ml enzyme solution (0.1% albumin 0.07% papaine, 0.5% dithiothreitol in 
calcium free isolating solution) for 30 minutes at 37°C and 25 rpm and then digested in a 
second enzyme solution (0.1% albumin, 0.1% collagenase, 0.1% hyaluronidase in isolating 
solution with 50 μM calcium) for 10 minutes at 37°C and 25 rpm. Aortal tissue pieces solved 
in 0.5-1.0 ml isolating solution were resuspended with a pasteur pipette for dissolution and 
seeded on cover slips (24 mm diameter) for culture.  
 
2.2.2.3 Cell culture and preparation for respirometric measurement 
All cell types were cultured in a normoxic atmosphere (21% O2 ~ pO2 158 mmHg, 5.3% CO2 
~ pCO2 40 mmHg, balanced with N2) in medium 199 with 10% FCS (PASMC and RASMC) or 
20% FCS (ASMC) and 1% P/S. The cells were characterized by immunoreactivity with α-
actin antibodies. The absence of endothelial cells was confirmed by staining for von 
Willebrand (vWF) factor, staining for cytokeratin was performed to exclude presence of 
epithelial cells, and staining for collagen I to exclude presence of fibroblasts. Cells were 
prepared for measurement by washing once with phosphate buffer saline (PBS: 0.8 % NaCl, 
0.02 % KCl, 0.115 % Na2HPO4 x 2H2O, 0.02 % KH2PO4, pH 7.4) and incubating with trypsin 
solution (0.25% (m/v)) for 2-5 minutes. The detached cells were then centrifuged 5 minutes 
at 5000 g. Afterwards they were washed two times with colorless medium 199 with 10% 
HEPES and resuspended to 2.5 ml for measurement in the O2k measurement chamber. 
Only cells from first and second passage were used.  
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2.2.2.4 Immunoflourescence staining 
PASMC, ASMC and RASMC were seeded onto eight-well chamber slides at 1500 cells per 
well. Cells were then washed with cold DPBS with 0.1% BSA and fixed and permeabilized 
with an ice-cold mixture of acetone and methanol for 5 min at -20°C. After washing 5 times 
with PBS with 0.1% BSA, slides were incubated in blocking buffer (3% BSA in PBS) for 15-
30 min at room temperature, followed by an 1 h incubation with the primary antibodies (SM-
α-actin 1:450, Cytokeratin 1:50, vWF 1:500 und Collagen I 1:5) at room temperature. 
Washing was followed by incubation with fluorescein isothiocyanate (FITC)-labeled 
secondary antibodies (1:100 in PBS with 0.1% BSA). As secondary antibody goat anti-
mouse was used for SM-α-actin und Cytokeratin (Alexa Fluor 488, goat anti-mouse IgG) 
staining and goat anti-rabbit (Alexa Fluor 488, goat anti-rabbit IgG) for vWF and collagen I. 
Nuclei were visualized by 4,6-diamidino-2-phenylindole (DAPI, 1:5000 in 0,1 % BSA) 
staining. Cells were washed 5 x with PBS, slides were covered with mounting medium and a 
cover slide and analyzed by fluorescence microscopy using the Leica CTR-MIC. 
 
2.2.3 Remission spectrophotometry 
2.2.3.1 Principle of spectral measurements 
Remission spectrophotometry can be used for determination of redox state of mitochondrial 
cytochromes. The method is based on the fact that certain cell pigments (cytochromes: cyto= 
cell, chrôma=color; greek) absorb light of specific wavelengths depending on their redox 
state. These cytochromes include heme proteins of red blood cells, mitochondria and other 
different enzymes. The absorption at specific wavelengths can be depicted as wavelength-to-
intensity diagram (i.e. spectrum). If mitochondrial cytochromes cannot transfer electrons 
("reduction"), they will exhibit different absorption characteristics ("reduced spectrum", Figure 
2.1) compared to the condition when they can release an electron ("oxidized spectrum", 
Figure 2.2). The change in reduction and oxidation (redox state) can be evaluated (Figure 
2.3) by comparing both spectra, which is accomplished by calculating reduced minus 
oxidized spectrum ("difference spectrum"). 
 
. 
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Figure  2.1 Spectrum of reduced mitochondria 
Negative intensity represents absorption (y-axis) at specific wavelengths (x-axis). The wavelength-to-
intensity/absorption curve (=spectrum) depicts the sum spectrum of single cytochromes. 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.2 Spectrum of oxidized mitochondria 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.3 Difference spectrum of reduced minus oxidized mitochondria  
Calculated by subtraction of reduced minus oxidized spectrum. 
The spectra of figure 2.1 to 2.3 were derived by measurements in PASMC.
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Inhibition of electron transfer (e.g. by removal of the terminal electron acceptor O2), will result 
in an electron retention ("reduction"), whereas release of electrons to O2 to form superoxide 
or water will result in "oxidation" (Figure 2.4). Therefore, inhibition of the mitochondrial 
respiratory chain by anoxia will result in a reduced difference spectrum as shown in Figure 
2.3. 
 
 
 
Figure  2.4 Reduction and oxidation of mitochondrial cytochromes  
If the final electron acceptor O2 is not available, electrons cannot be passed along the mitochondrial 
respiratory system and the cytochromes are reduced (A). Under conditions of O2 availability the 
electrons can be passed to O2 to produce superoxide or water, the cytochromes are oxidized (B). 
 
2.2.3.2 Measurement of redox state in isolated rabbit and mouse lungs 
2.2.3.2.1 Setup for measurement in isolated lungs 
 
In order to analyze absorption properties of the mitochondria, the wavelength dependent 
change of light irradiated into tissue ("broadband spectrum") compared to backscattered (i.e. 
remitted) light from tissue ("remission spectrum") is detected. Afterwards, the difference 
spectrum of remission spectrum under condition A (e.g. during hypoxia) minus remission 
spectrum under condition B (e.g. normoxia) can be calculated. The measurement depth will 
depend on the distance between the illuminating light spot and the collected backscattered 
light (Figure 2.5). 
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Figure  2.5 Schematic setup for measurement of remission difference spectra 
Light of a known spectrum (broadband spectrum) is sent into tissue, where it interacts with boundary 
layers (reflection), small particles (scattering) and cytochromes (absorption). On its way through tissue 
it is therefore changed in its spectrum. The backscattered part of the altered light is collected at the 
tissue surface by a fiber optic lightguide and forwarded to the spectrometer for quantification of the 
intensity at the different wavelengths (remission spectrum). Remission spectra at different conditions 
can be compared and are depicted as difference spectra. 
 
Measurement of remission difference spectra were performed by a spectrophotometric 
system using a CytoSPEC II (Figure 2.6). This consists of a temperature- and current-
controlled broadband optical fiber source (395-670 nm) for illumination, and a temperature-
controlled spectrophotometer with an asymmetric crossed Czerny-Turner design (detection 
range of 390-650 nm; optical resolution of 1.5 nm) for detection and quantification of light. 
Spectra were acquired at a rate of 3 – 800 ms, depending on the optical properties of the 
sample, and averaged over a period of 2 s up to 10 s. Calculation of difference spectra was 
performed by the CytoSPEC II software. A newly developed fiber-optic light guide (LEA flat 
probe for rabbit, LEA endoscopic probe for mouse) fixed at the surface of the lung (Figure 
2.7) was used for collection of spectra. 
For measurements in the rabbit lung, the separation of illuminating and sampling spot was 
set at 4 mm in order to maximize measured tissue volume. 
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Figure  2.6 CytoSPEC II  
CytoSPEC II consists of the broadband optical fiber source, the spectrometer for analysis of 
backscattered light and the software for calculation of difference spectra. The fiber optic lightguide is 
connected to the optical fiber source and spectrometer. 
 
 
                                                            
A                    B 
 
Figure  2.7 LEA flat and endoscopic probe 
LEA flat probe (A) or LEA endoscopic probe (B) are fixed at the surface of isolated rabbit or mouse 
lungs, respectively. The probes consist of separated illuminating (yellow) and detecting (arrow) fibers 
with a different distance between the fibers to set the depth of the measurement sample.
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Figure  2.8 Setup for measurement in isolated lungs 
The isolated lung is ventilated via the trachea and perfused via the pulmonary artery (PA). Perfusate 
from the lung is collected in the left ventricle (LV). The lung is freely suspended from a weight 
transducer. The flexible fiber optic light guide is softly attached to the lung surface, allowing it to follow 
the movement of the ventilatory excursion of the lung. The whole lung is covered by a black tissue to 
avoid artefactual light incidence (here uncovered for demonstration purposes).  
   
2.2.3.2.2 Experimental procedure 
 
In isolated rabbit and mouse lungs periods of 15 minutes normoxic ventilation were 
alternated with 10 minutes of hypoxic ventilation. Hypoxia was applied by ventilation with gas 
mixtures of 0% (0 mmHg), 1% (8 mmHg), 3% (23 mmHg), 5% (38 mmHg), 7% (53 mmHg), 
10% (75 mmHg) and 15% (158 mmHg) O2 (pO2) with 5% (38 mmHg) CO2 (pCO2, balanced 
with N2) chosen in a random order. Pulmonary arterial pressure, pulmonary venous pressure, 
ventilation pressure, lung weight and cytochrome spectra were recorded continuously. 
Cytochrome difference spectra were calculated as follows: Remission spectra were recorded 
every second and averaged over one minute. The averaged spectra of the minute before 
switching to hypoxia (spectrum 1), the fifth minute after switching to hypoxia (spectrum 2), 
the minute before switching to normoxia (spectrum 3) and the fifth minute after switching to 
normoxia (spectrum 4) were used for calculation of two difference spectra by subtraction of 
spectrum 1 from spectrum 2 and spectrum 4 from spectrum 3. Both difference spectra were 
averaged to achieve the final difference spectrum at a specific hypoxic condition. This 
procedure allows for correction of potential time dependent spectral alterations, as the 
normoxic spectrum once taken before hypoxia (spectrum 1) and once taken after hypoxia 
(spectrum 4) is subtracted from the hypoxic spectrum. 
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Figure  2.9 Experimental procedure for redox measurements in isolated lungs 
 
2.2.3.3 Measurement in cell suspensions 
2.2.3.3.1 Experimental setup 
 
Measurements in cell suspension were based on the same principle as described for light 
interaction with tissue in the isolated lung (see Figure 2.5). Measurements were performed in 
a closed chamber of the Oxygraph-2k (O2k, OROBOROS, Innsbruck, Austria) with 
integrated fiber-optic light guides from the CytoSPEC II. Light of the broadband optical fiber 
source (395-670 nm) illuminated the cell suspension via glass fiber probes integrated into the 
stopper of the measurement chamber (Figure 2.10 and 2.11). The light interacted with the 
cells and was collected by the glass fiber probe for spectrometer analysis (Figure 2.10). 
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Figure  2.10 Schematic setup for measurement in cell suspensions 
Light of a known spectrum (broadband spectrum) is irradiated into the cell suspension via a fiber optic 
light guide. There it interacts with small particles, like mitochondria and cells (scattering) and 
cytochromes (absorption). On its way through the cell suspension it is therefore changed in its spectral 
characteristics. The backscattered part of the altered light is collected by the fiber optic lightguide and 
sent into the spectrometer for quantification and calculation of difference spectra. 
 
 
                                                        
 
Figure  2.11: Light fiber probe for Oxygraph-2k (O2k) chamber 
Light fiber probe (blue) integrated into stopper (white) of the measurement chamber 
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Figure  2.12 Setup of redox measurement in cell suspension 
 
2.2.3.3.2 Experimental procedure 
 
2.5 ml of cell suspension (2.5-5 million cells/ml) prepared as described above were filled into 
the measurement chamber of the O2k. After ten minutes of equilibration with room air, the 
chamber was sealed air-tight with the glass fiber integrated stopper and spectra were 
recorded continuously. O2 concentrations decreased according to mitochondrial respiration. 
After reaching anoxia, the chamber was opened and the cell suspension reoxygenated. O2 
partial pressure was calibrated by a two-point calibration procedure with defined O2 
concentrations of room air (21% O2 ~ pO2 158 mmHg) and anoxia (0% O2, pO2 0 mmHg) 
(see methods 2.2.4). Remission spectra recorded at specific O2 concentrations were 
subtracted from recorded normoxic spectra (18% O2, pO2 137 mmHg) to calculate hypoxic 
difference spectra.  
 
2.2.4 High-resolution respirometry and O2 kinetics 
Mitochondrial respiration was determined at 37 °C by high-resolution respirometry using an 
Oxygraph-2k (Figure 2.13). Due to the high sensitivity of the pO2 sensor (O2 consumption <2 
pmol . s-1 . cm-3, signal-to-noise  ±0.02 mmHg [0.00 % O2]) and high temporal resolution, this 
system allows analysis of the O2 kinetics of cellular respiration. Cellular O2 consumption (JO2) 
was calculated from the time derivative of O2 concentration (2 s time-intervals) and corrected 
for the background of the instrumentation and the response time of the O2 sensor (2-3.5 s). A 
CytoSPEC II Oroboros O2k 
Glas fibre probe 
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two-point calibration was performed for all experiments by equilibration with 21% O2 adjusted 
to air pressure (pO2 ~ 158 mmHg) and sodium dithionate (SDT) (zero O2). The O2 
consumption compared to pO2 exhibited biphasic kinetics. A typical recording is illustrated in 
Figure 2.14. The linear part at high O2 concentrations can partially be attributed to decreased 
mitochondrial respiration, due to loss of function, and non-mitochondrial respiration, which 
illustrates that O2 consumption measurement alone does not allow for a complete description 
of the reaction of the mitochondrial respiratory system to hypoxia [186]. Therefore, the O2 
affinity of the cells was studied in transition from aerobic to anoxic states. Below a pO2 of 
1.1% O2 (pO2 8.3 mmHg) a hyperbolic fit of the O2-dependent respiration allows 
determination of p50 of mitochondrial respiration [117, 186]. p50 is the O2 concentration at 
which the cellular respiratory rate is half-maximal. This parameter was calculated plotting O2 
consumption at specific O2 concentration (JO2) as a function of O2 concentration (pO2) and 
fitting the hyperbolic function JO2 = (Jmax· pO2)/(p50 + pO2) for the pO2 range of 0 – 1.1% O2 
(pO2 8.3 mmHg), where Jmax is the maximal O2 consumption (Figure 2.15). All calculations 
were performed with Datlab software (OROBOROS, Innsbruck, Austria) as described [198-
200]. All measurements in cell suspensions were performed in intact cells in medium 199. As 
determination of p50 is adjusted to the currently measured air pressure, O2 concentrations for 
p50 value are given as pO2 in mmHg and for comparison in % O2 in brackets (assuming air 
pressure of 750 mmHg). 
 
Figure  2.13 Oxygraph-2k (O2k) from Oroboros for high-resolution respirometry
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Figure  2.14 Mitochondrial and non-mitochondrial respiration  
The O2 consumption in pulmonary arterial smooth muscle cells (PASMC) (black line) was calculated 
by the first derivative of O2 concentration (grey line). The decrease in O2 consumption due to non-
mitochondrial O2 consumption and cell damage is depicted by the hatched area.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.15 Determination of O2 affinity (p50) 
p50 was calculated plotting O2 consumption (JO2) as a function of O2 concentration and fitting the 
hyperbolic function J02 = (Jmax· pO2)/(p50 + pO2) for the pO2 range of 0 – 8.3 mmHg (1.1% O2), where 
Jmax is maximal O2 consumption.
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2.2.5 Mitochondrial membrane potential and mitochondrial matrix 
superoxide measurement 
Mitochondrial membrane potential was measured in a flow-through system in isolated cells 
using JC-1 as a ratiometric indicator dye. Mitochondrial ROS production was measured with 
MitoSox.  
For measurements with JC-1 cells plated on coverslips were incubated for 20 minutes at 
37 °C in medium 199 containing 1 µg/ml JC-1. MitoSox measurements were performed after 
incubation with 5µM MitoSox for 20 min in PBS. For microscopic analysis coverslips were 
then placed in a 0.5 ml volume glass-covered perfusion chamber, perfused (2 ml/min) with 
Hepes-Ringer-Buffer (HRB: 5.6 mM KCl, 136.4 mM NaCl, 1.0 mM MgCl2, 2.2 mM CaCl2, 
11.0 mM Glucose, 10 mM HEPES, pH 7.4) saturated with O2 (21% O2, pO2 158 mmHg) and 
maintained at 32.0 ± 0.2°C by heating both the HRB and the chamber. Hypoxia was induced 
by switching the perfusing medium from normoxic medium to medium of different levels of 
hypoxia (bubbled with N2). For JC-1 measurements the excitation wavelength was set at 480 
nm, and emitted light was collected with a CCD camera at 530 and 590 nm. Membrane 
hyperpolarization leads to a reversible change in fluorescence emission from green (530 nm) 
to red (590 nm) when JC-1 is excited at 480 nm [201]. MitoSox measurements were 
performed at 510 nm for excitation and 580 nm for emission [201, 202]. 
  
2.2.6 Statistics 
Results are presented as means ± SEM. One-way ANOVA with Dunnett’s post hoc test was 
performed for comparison of respiration at different O2 concentrations with respiration at a 
pO2 of 137 mmHg serving as control group. A one-way-ANOVA with the Student-Newman-
Keuls post hoc test was performed for the comparison of redox states of different 
cytochromes, strength of HPV, mitochondrial membrane potential and ROS measurements. 
A Student’s t-test was used for the comparison of two groups. 
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3 Results 
3.1 Remission spectrophotometry in isolated lungs and cell 
suspensions 
3.1.1 Evaluation of tissue cytochrome spectra 
Mitochondrial cytochromes were identified in the isolated lung by addition of cyanide for 
complete reduction of all mitochondrial cytochromes (Figure 3.1) and by comparison with 
mitochondrial cytochrome reference spectra derived from literature (see appendix). The 
spectral alterations in the lung at 0% O2 (pO2 0 mmHg) were only partially congruent to the 
mitochondrial spectra. For comparison of cytochromes that might contribute to the hypoxia-
induced sum spectrum, the spectra of non-mitochondrial cytochromes are depicted in Figure 
3.1. Cytochrome b558 was reduced by SDT during anoxic ventilation (see 3.3.1), and 
cytochrome P450 by ventilation with carbon monoxide (see 3.3.2). Hemoglobin was identified 
by addition of blood (see 3.3.5). These cytochromes could partially contribute to the 
spectrum derived during ventilation with anoxic gas ("0% O2").  
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure  3.1 Cytochrome spectra in the isolated lung 
Difference spectra of hemoglobin, cytochrome P450 and NADPH oxidase were acquired in isolated 
lungs as described above. Data are from n=3 different lung preparations for each cytochrome. 
Mitochondrial cytochrome reference spectra are derived from literature (see appendix). Spectral 
alterations during ventilation with 0% O2, as well as after application of cyanide for demonstration of 
mitochondrial cytochromes are given for comparison (n=5 lung preparations). 
410 425 440 455 470 485 500 515 530 545 560 575 590 605 620
-0.02
Wavelength [nm] 
Hemoglobin 
NADPH oxidase 
Cyanide 
In
te
ns
ity
[A
U
]
0 % O2 
Cytochrome P450 
aa3
bl/h c 
Mitochondrial 
cytochrome 
 reference  
  spectra 
0.01 
Results 55
3.1.2 Evaluation of scattering, reflection and water content in 
tissue 
In tissue remission spectrophotometry the spectrum is not only altered by absorption of light, 
but also by wavelength dependent scattering and reflection (see Figure 2.5). Scattering 
phenomenon was illustrated in milk as a scattering medium, where light is backscattered by 
lipid droplets. Light of the same intensity at every wavelength was irradiated into milk and the 
backscattered light exhibited a spectrum shown in Figure 3.2. The backscattering 
phenomenon resulted in higher intensities of detected light at high wavelengths.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.2 Spectrum of white light backscattered by milk 
Intensity of light at low wavelengths was lower compared to that at high wavelengths, indicating that 
light at lower wavelengths is less backscattered. Spectrum is shown from one representative 
measurement. 
 
 
In tissue the light is additionally influenced by reflection at boundary layers, e.g. when 
crossing compartments of high and low water content, and by alterations in density of tissue 
due to ventilatory excursion or edema development. To evaluate the influence of tissue water 
content, it was increased by increasing pulmonary venous pressure or decreased by non-
hypoxia-induced vasoconstriction with the thromboxane mimetic U-46619 (Figure 3.3). The 
resulting spectra are given in Figure 3.3. and resembled lung remission spectra as detected 
by measurement of light backscattered from lung tissue during normoxic ventilation. 
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Figure  3.3 Influence of tissue water content on difference spectra 
Decreased absorption (volume load, n=3 lung preparations) or increased absorption (vasoconstriction 
by thromboxane mimetic U46619, n=5 lung preparations) was the result of lower or higher density, 
respectively, of absorption particles (=tissue) in the measurement volume and/or result of increased 
reflection.  
 
3.1.3 Evaluation of cellular cytochrome spectra 
As basis for the identification of measured difference spectra in isolated cells previously 
reported mitochondrial cytochrome difference spectra were used (Figure 3.4 and appendix). 
Additionally, reference absorption spectra for single cytochromes were determined in the 
closed chamber system. As a reference spectrum of cytochrome c, difference spectra were 
acquired from purified bovine cytochrome c. The reference spectrum for cytochrome bl/h of 
complex III was measured by reducing cytochrome bl/h in isolated PASMC with antimycin A. 
This provides difference spectra for cytochrome bh (b562) and bl (b566). Subsequently, 
cytochrome aa3 difference spectra were calculated from maximally-reduced PASMC spectra 
minus cytochrome bl/h and cytochrome c. Cytochromes a and a3 could not be distinguished, 
as determined by differential reduction of cytochrome a with cyanide. Cytochrome c1 and b560 
of complex II was also not visible. Results of measured reference spectra are provided in 
Figure 3.4 and the appendix.  
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Figure  3.4 Reference spectra and anoxic difference spectrum 
Reference spectra for cytochrome aa3, bl/h and c were derived as described above and are depicted 
as red, green and blue areas, respectively. For comparison a measured reduced sum spectrum (black 
line), acquired by calculation of the difference spectrum of anoxic minus normoxic spectra of PASMC 
(= anoxic difference spectrum) is displayed. Data are from n=3 experiments. Reference spectra taken 
from literature are shown as red, green and blue lines (lit. cyt. aa3, bl/h, c). 
 
The comparison of the measured anoxic difference spectrum with the reference spectra of 
the single cytochromes suggests that mainly mitochondrial cytochromes contribute to the 
measured anoxic difference spectrum. To support this hypothesis the spectrum was 
compared to spectral alterations after application of cyanide which specifically reduces 
mitochondrial cytochromes. The cyanide reduced spectrum was almost identical with the 
anoxia derived spectrum (Figure 3.5).  
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Figure  3.5 Mitochondrial reduction by anoxia and cyanide 
Comparison of a fully reduced PASMC spectrum (PASMC anoxia, n=9 experiments) with a cyanide-
inhibited PASMC spectrum (PASMC cyanide, n=4 experiments). The difference spectrum of anoxia 
minus cyanide spectrum illustrates congruence of both spectra.  
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3.1.4 Evaluation of scattering interference in cell suspensions 
In cell suspension scattering properties are dependent on mitochondrial and cellular shape, 
as well as on their size. To simulate scattering changes cells were permeabilized by digitonin 
(Figure 3.6) and typical scattering alterations could be detected (please compare to Figure 
3.2). In contrast, dilution of cell suspension by addition of medium resulted in higher 
intensities of the spectral light due to less absorption in the measurement volume (Figure 
3.6), similar to the pattern provoked by increased tissue water content (Figure 3.3).  
 
 
 
Figure  3.6 Spectral changes induced by addition of digitonin or medium 
Increasing concentrations of digitonin resulted in decreased scattering due to destruction of cells and 
mitochondria. The typical wavelength dependent change in intensity can be seen. Dilution of the cell 
suspension with medium resulted in increased intensities (=decreased absorption), as the 
concentration of absorbing particles in the measurement volume decreased. Data are from n=3 
experiments. 
 
Scattering in cell suspension can influence the quantitative evaluation of absorption changes, 
as it leads to the effect that the relationship between intensity of backscattered light and 
absorption is not linear. The concentration of an absorbing protein (cytochrome c) was 
compared with the intensity of the backscattered light. A linear correlation between the 
concentration of cytochrome c and the backscattered light intensity at 550 nm and 415 nm 
was found (Figure 3.7). Therefore, if scattering is constant, changes of light intensity of 
backscattered light correlate linearly to absorption changes.  
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Figure  3.7 Cytochrome c concentration in comparison to light attenuation  
Light attenuation at 415 nm and 550 nm (see spectrum cytochrome c in appendix) and linear 
correlation between measured light intensity and cytochrome c concentration is depicted. 
Measurements are performed with HL60 cells (6-7 Mio cells/ml, Cytochrome c concentration was 0.2-
13.0 µl, n=25 of 4 separate experiments). 
 
However, scattering changes cannot be excluded to occur during hypoxia. As scattering 
alterations would have non linear impact on measured intensities depending on wavelength 
(see Figure 3.2), the scattering alterations should be reflected by different results, when 
analyzing the redox state at low or high wavelength ranges. This was excluded by 
measurements in the low O2 range, showing similar redox alterations, when analyzed in the 
low and high wavelength range (Figure 3.8).  
 
Figure  3.8 Analysis of redox state at different wavelength ranges  
Least square fitting, as described below, was performed in the low (415-460 nm, full bars) and high 
(500 -620 nm, hatched bars) wavelength range and calculated reduction levels of the different 
wavelength ranges were compared to each other (depicted as relative reduction referred to maximal 
reduction measured at anoxia). No significant differences between the wavelength ranges for 
cytochrome aa3 (red), bl/h (green) or c (blue) could be detected (n=6). 
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3.1.5 Semiquantitative analysis of cytochrome redox state based 
on difference spectra   
Difference spectra were calculated by subtraction of normoxic spectra from hypoxic spectra 
(normoxia: in the isolated lung 21% O2 [pO2 158 mmHg], in cell suspensions 18 % O2 [pO2 
135 mmHg] reached after equilibration), as described above.  
Difference spectra were used to calculate changes in cytochrome redox states. Reference 
spectra of single cytochromes were fit in the measured sum difference spectrum by multi-
wavelength least-square fitting (TechPlot, Sftek, Braunschweig, Germany). As shown in 
Figure 3.9, the measured sum difference spectrum (= measured reduced spectrum, open 
circles) was almost identical with the sum difference spectrum that was recalculated on the 
basis of the single reference spectra (= fitted spectrum, black line). 
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Figure  3.9 Fitting of mitochondrial spectra 
Fitting of single mitochondrial spectra into anoxic difference spectra of isolated pulmonary arterial 
smooth muscle cells (PASMC). Data are from n=3 experiments. 
l/h 
0.00  
Results 62
3.2 Mitochondria as oxygen sensors 
3.2.1 Mitochondrial complex IV in oxygen sensing of HPV 
3.2.1.1 Hypoxia-induced inhibition of the mitochondrial electron transport system 
and HPV in the isolated lung 
Isolated blood-free perfused lungs were ventilated with different O2 concentrations, resulting 
in alveolar O2 concentrations (PAO2) of 0-15% O2 (pO2 0-113 mmHg) for 10 minute periods, 
alternating with 15 minute periods of normoxic ventilation (21% O2, pO2 158 mmHg).  The 
different O2 concentrations were applied in each lung preparation in random order. Increases 
in pulmonary arterial pressure (∆ PAP) during hypoxic ventilation were detected at a PAO2 of 
≤ 10% O2 (pO2 ≤ 75 mmHg) (Figure 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.10 O2 dependency of HPV  
The strength of HPV is given as the maximum increase in pulmonary arterial pressure (∆PAP) during 
10 minute periods of hypoxic ventilation for the depicted O2 concentrations. Data are from n=5 lung 
preparations. * indicates significant differences compared to normoxic ventilation (21% O2, pO2 158 
mmHg). * p<0.05, ** p<0.005, *** p<0.001. 
 
Parallel determination of difference spectra by remission spectrophotometry showed first 
detectable changes at a PAO2 of 10% O2 (pO2 75 mmHg). Further spectral alterations were 
observable at a PAO2 of ≤ 5 % O2 (pO2 ≤ 38 mmHg) in the range of 520-590 nm and at a 
PAO2 of 0 % O2 (pO2 0 mmHg) in the ranges of 410-460 nm and 500-630 nm (Figure 3.11). 
As reference, a difference spectrum after total reduction of mitochondrial cytochromes with 
cyanide, as well as reference spectra for cytochrome c (420/550 nm), bl/h (430/563 nm), and 
aa3 (445/603/605 nm) are provided. 
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Figure  3.11  Hypoxia-dependent alterations of remission spectra 
Difference spectra were assessed by subtraction of normoxic from hypoxic spectra for repetitive 
hypoxic ventilation maneuvers corresponding to Figure 3.10. Spectra in the presence of cyanide (80 
µM) and bolus of thromboxane mimetic U46619 (0.5 nM) were recorded at the end of each 
experiment. Reference spectra for single cytochromes are depicted for comparison. Data are from n=5 
lungs.  
 
When comparing the reference mitochondrial and non-mitochondrial spectra (Figure 3.1 and 
3.11) to the hypoxia-induced spectral alterations, only the spectral alterations in the 
wavelength range of 600 - 610 nm could be clearly assigned to reduction of cytochrome aa3 
correlating to an inhibition of complex IV. The other hypoxia-induced spectral alterations 
showed overlapping features of mitochondrial cytochromes, non-mitochondrial cytochromes 
and spectral alterations caused by scattering changes in consequence of vasoconstriction 
(see thromboxane spectrum Figure 3.3 and Figure 3.1). The reduction of mitochondrial 
cytochrome aa3, peaking at 445 nm and 603/605 nm could only be detected at a PAO2 of 0 % 
O2 (pO2 0 mmHg), so that at higher O2 ranges, mitochondrial respiration seemed to be largely 
unrestricted. 
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3.2.1.2 Hypoxia-induced inhibition of the mitochondrial electron transport system 
and HPV in isolated PASMC 
3.2.1.2.1 Redox changes in isolated PASMC 
 
As remission spectroscopy in intact lungs is limited by the fact that the sum spectra of all 
pulmonary cells is detected, but PASMC are thought to be the sensor cells of at least acute 
HPV (lasting seconds to minutes), cytochrome redox alterations in isolated PASMC were 
measured by combination of respirometry and spectrophotometry and compared with the 
strength of HPV. Difference spectra from PASMC under different O2 concentrations showed 
similar alterations as observed in isolated lungs at anoxic ventilation (Figure 3.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.12 O2-dependent alterations of remission difference spectra in PASMC 
Hypoxic difference spectra of pulmonary arterial smooth muscle cells (PASMC) were assessed by 
subtraction of normoxic from hypoxic spectral values. Negative intensity represent absorption peaks at 
specific wavelengths for single cytochromes (cytochrome c [420/550 nm], bl/h [430/563 nm], and aa3 
[445/603/605 nm]). Fitting of single cytochromes to quantify absorption is shown in Figure 3.13. Data 
are from n=9 experiments (from n=6 independent cell preparations). 
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At 0 % O2 (pO2 0 mmHg) clear alterations of mitochondrial cytochromes, congruent with 
alterations induced by cyanide (see Figure 3.5) could be detected. At higher O2 
concentrations far smaller redox changes, exceeding the level of signal-to-noise ratio at 
about 5 % O2 (pO2 38 mmHg) could be seen. Compared to spectral alterations in the isolated 
lung, no changes in the wavelength range of 410-440 nm could be detected at mild hypoxia.  
Fitting of mitochondrial cytochromes into measured remission difference spectra was 
performed for each O2 concentration. While a reduction of cytochrome bl/h was only 
detectable at O2 concentrations of ≤ 1% O2 (pO2 ≤ 8 mmHg), cytochrome c was already 
reduced at 5% O2 (pO2 38 mmHg) in PASMC. For cytochrome aa3, reduction was observed 
at ≤ 3% O2 (pO2 ≤ 23 mmHg) (Figure 3.13). The O2 dependency of redox alterations 
paralleled respiration determined by high-resolution respirometry (Figure 3.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.13 O2 dependency of cytochrome redox alterations in PASMC 
Reduction of cytochromes aa3, bl/h, c in pulmonary arterial smooth muscle cells (PASMC) between 15-
0% O2 (pO2 113-0 mmHg). For comparison, the reduction in respiration from Figure 3.14 is depicted. 
Data are from n=16 experiments from n=8 independent cell preparations. *, #, † indicate significant 
differences of cytochrome aa3, bl/h, and c compared to normoxia (p<0.05).  
 
 
Taking into account the higher sensitivity of redox measurements in isolated PASMC due to 
lower interference by scattering and cytochromes of other cell types, the results are 
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inhibition of mitochondrial respiratory chain could be detected in both experimental setups at 
0% O2 (pO2 0 mmHg). However, in PASMC small reduction of cytochromes was also 
detected at O2 concentrations of 5 and 3% O2 (pO2 38 mmHg and 23 mmHg) resembling 
hyperbolic inhibition kinetics similar to respiration. Redox changes at higher O2 
concentrations are beyond sensitivity of the method and obscured by signal-to-noise ratio.  
 
3.2.1.2.2 Respiration in isolated PASMC 
 
Another very sensitive measure for the activity of the mitochondrial respiratory chain is the 
determination of respiration. High resolution respirometry allows measurement of respiration 
at very low O2 concentrations and thus determination of O2 concentration at half-maximal 
respiration (please see 2.2.4). 
O2 concentration at half-maximal respiration (p50) for PASMC was calculated to be a pO2 of 
0.8 ± 0.0 mmHg (0.1 % O2). From these values respiration at any O2 concentration can be 
calculated and compared to maximal respiration at normoxia (21% O2, 158 mmHg). Hence 
the first significant inhibition of respiration was found at pO2 levels of ≤ 105 mmHg (≤ 14% 
O2) in PASMC (Figure 3.14). Thus inhibition of respiration occurs in an O2 range, when HPV 
occurs. 
 
 
0.8
0.9
1
0 20 40 60 80 100 120
V
/V
[m
ax
]
 
 
 
Figure  3.14 O2 dependency of respiration in PASMC  
Mean and SEM of original recording from pulmonary arterial smooth muscle cells (PASMC) (n=9). 
Respiration at different O2 concentrations, calculated from p50. Bar indicates significant decrease in 
respiration compared to 21% O2 (158 mmHg). 
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3.2.2 Mitochondrial complex III in oxygen sensing of HPV 
In the next step measurements focused on the regulation of cytochrome bl/h compared to 
cytochrome aa3 and c during hypoxia. After analysis of hypoxia-induced redox alterations, it 
became evident, that cytochrome bl/h was reduced only at O2 concentrations ≤ 1% O2 (pO2 ≤ 
8 mmHg), whereas cytochrome aa3 and c became already significantly reduced at 
concentrations ≤ 3% O2 (pO2 ≤ 23 mmHg) and 5% O2 (pO2 38 mmHg), respectively (Figure 
3.13). When comparing the redox state of cytochrome bl/h directly with cytochrome aa3 and 
c, a higher oxidation state of cytochrome bl/h compared to cytochrome aa3 and c could be 
found at 1 and 3% O2 (pO2 8 and 23 mmHg) (Figure 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.15 Differential regulation of mitochondrial cytochromes in PASMC 
Comparison of redox alterations of cytochrome aa3, bl/h, c in pulmonary arterial smooth muscle cells 
(PASMC). Data are from n=16 individual experiments from at least n=8 independent preparations.       
* indicate significant differences of cytochrome aa3, bl/h, or c compared to normoxia (p<0.05).              
# indicate significant differences of cytochrome aa3 and c, compared to cytochrome bl/h (p<0.05). 
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The higher oxidation state of cytochrome bl/h could indicate an electron leak at complex III. 
Thus mitochondrial ROS production was measured. These experiments revealed an O2-
dependent ROS production, correlating with redox state of cytochrome bl/h. 
       
 
 
 
 
 
 
 
 
 
 
 
Figure  3.16 Hypoxia-dependent alterations of mitochondrial superoxide 
concentration in PASMC  
Data are from n=3 individual experiments. 
 
As mitochondrial membrane hyperpolarization is known to favor ROS production, 
mitochondrial membrane potential was determined. These experiments revealed an O2-
dependent increase of mitochondrial membrane potential, correlating with cytochrome redox 
states. 
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Figure  3.17 Hypoxia-dependent changes of mitochondrial membrane potential in 
PASMC 
Data are from n=3 individual experiments. 
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3.2.3 Comparison of PASMC to arterial smooth muscle cells of the 
systemic vasculature 
When comparing the hypoxia-induced reduction of mitochondrial cytochromes in PASMC 
with that of ASMC and RASMC, the reduction level of PASMC, ASMC and RASMC did not 
differ significantly (Figure 3.18). 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.18 Comparison of redox alterations of cytochrome aa3, bl/h, c in PASMC, 
ASMC and RASMC 
Data are from at least n=7 individual experiments from at least n=4 independent preparations.             
* indicate significant differences of cytochrome aa3, bl/h, or c compared to normoxia (p<0.05).               
# indicate significant differences of cytochrome aa3 and c, compared to cytochrome bl/h (p<0.05).
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However, hypoxia inhibited respiration less in RASMC compared to PASMC and ASMC, 
represented by higher pO2 at half maximal respiration (p50) depicted in Figure 3.19. Half-
maximal respiration (p50) for PASMC was calculated to be a pO2 of 0.8 ± 0.0 mmHg (0.1 ± 
0.0% O2), 0.8 ± 0.1 mmHg (0.1 ± 0.0% O2) for ASMC, and 0.6 ± 0.0 mmHg (0.1 ± 0.0% O2) 
for RASMC (Figure 3.19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.19 O2 affinity of PASMC, ASMC, and RASMC  
Calculated as the O2 concentration at half maximal respiration (p50; n=5-9 experiments). * indicate 
significant difference compared to PASMC and ASMC. 
 
As increased ROS production was detected in PASMC during hypoxia, ROS production was 
next determined in RASMC and ASMC.  
Although similar to PASMC cytochrome bl/h was more oxidized in hypoxia compared to 
cytochrome c in RASMC (Figure 3.18), in contrast to PASMC no increase in ROS production 
could be detected in RASMC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.20 Hypoxic mitochondrial superoxide concentration in PASMC, ASMC and 
RASMC 
O2 concentration was reduced from normoxia to 1% O2 (pO2 8 mmHg). * indicates significant 
difference compared to normoxia (** p<0.005). 
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As a possible explanation for the different ROS production of PASMC and RASMC the 
finding may serve, that mitochondrial membrane potential in RASMC was not increased 
during hypoxia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.21 Hypoxic mitochondrial membrane potential in PASMC, ASMC and 
RASMC 
O2 concentration was reduced from normoxia to 1% O2 (pO2 8 mmHg). * indicate significant difference 
compared to normoxia (*** p<0.001). Data are from n=3 individual experiments. 
 
 
In summary, in PASMC redox alterations and inhibition of mitochondrial respiration occurred 
at O2 concentrations at which hypoxia-induced ROS production and mitochondrial membrane 
hyperpolarization could be detected. The respiration of RASMC was slightly less inhibited by 
hypoxia than the respiration of PASMC or ASMC and neither ROS production, nor 
mitochondrial membrane hyperpolarization could be found in RASMC during hypoxia. 
With regard to the isolated lung, mitochondrial respiration was slightly inhibited at O2 
concentrations, at which HPV occurred in isolated lungs. Spectral alterations in the isolated 
lung that can be attributed to mitochondrial cytochromes were similar to the redox changes 
measured in PASMC, but multiple spectral alterations that can be assigned to scattering 
phenomena and non-mitochondrial cytochromes overlapped mitochondrial cytochromes. 
Therefore, inhibition of respiration and mitochondrial cytochrome redox alterations could be 
responsible for hypoxia-induced events in PASMC and for initiation of HPV in isolated lungs.  
 
In order to confirm the findings and to overcome the limitations of hypoxic measurements in 
the isolated lung, in the next approach HPV was manipulated by mitochondrial inhibitors and 
correlated to redox changes and respiration under these conditions. 
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3.2.4 Correlation of HPV to respiration and redox state during 
application of mitochondrial inhibitors 
3.2.4.1 Correlation of HPV with redox state of mitochondrial cytochromes 
3.2.4.1.1 Application of cyanide 
 
Inhibition of complex IV by cyanide resulted in a dose-dependent decrease of HPV. In the 
absence of cyanide, the strength of HPV was 3.0 ± 0.5 mmHg at a PAO2 of 3 % O2 (pO2 23 
mmHg) (n=4). The decrease of the strength of HPV during application of cyanide paralleled 
the reduction of mitochondrial cytochromes, particularly of cytochrome c (Figure 3.22). 
Cytochrome bl/h was significantly less reduced than cytochrome aa3 and c by cyanide 
treatment (Figure 3.22). In parallel with inhibition of HPV, cyanide induced a vasoconstriction 
during normoxic ventilation determined as a PAP increase of 0.8 ± 0.2 mmHg (n=4).  
 
 
 
        
Figure  3.22 HPV and redox state at different cyanide concentrations in the isolated 
lung 
Data are given in percent of maximal reduction or maximum strength of HPV, respectively (% max. 
response) * significant difference compared to cytochrome c (p<0.05).  
 
Similar results were found in isolated PASMC. After adding cyanide to the cell suspension 
the cytochromes became increasingly reduced in normoxia and therefore the difference from 
normoxia to the fully reduced cytochromes in anoxia was decreased. The maximum 
response was defined as the reduction between normoxia and anoxia without presence of 
cyanide. Except for 10µM cyanide, cytochrome reduction paralleled HPV.  
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Figure  3.23 HPV and redox state at different cyanide concentrations in PASMC 
Inhibition of HPV compared to the maximal reduction of mitochondrial cytochromes at different 
cyanide concentrations in isolated pulmonary arterial smooth muscle cells (PASMC). 
Data are from n=3 experiments. 
 
3.2.4.1.2 Application of 2-n-heptyl-4-hydroxyquinoline-N-oxide (HQNO) 
 
Interference of electron transfer at the Qi site of complex III by HQNO resulted also in an 
inhibition of HPV. In isolated lungs HQNO reduced cytochrome bl/h and oxidized cytochrome 
c to a similar extend as it inhibited HPV (Figure 3.24). In normoxia no change of PAP could 
be detected. 
 
  
 
Figure  3.24 HPV and redox state at different HQNO concentrations in the isolated 
lung  
Data are given in percent of maximal reduction or maximum strength of HPV, respectively (% max. 
response). Data are from n=4 isolated lungs. 
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After application of HQNO in cell suspensions normoxic spectra were taken as reference 
spectra. The difference of these spectra to maximally reduced anoxic spectra decreased with 
increasing concentrations of HQNO, as HQNO inhibited electron flow through the respiratory 
chain. Cytochrome reduction correlated with strength of HPV. 
      
Figure  3.25 HPV and redox state at different HQNO concentrations in PASMC  
Inhibition of HPV compared to the maximal reduction of mitochondrial cytochromes at different HQNO 
concentrations in isolated pulmonary arterial smooth muscle cells (PASMC). 
Data are from n=3 experiments. 
 
3.2.4.1.3 Application of rotenone 
 
Inhibition of complex I by rotenone inhibited HPV, but resulted in no detectable redox change 
during normoxia or hypoxia (PAO2 of 3 % O2, pO2 23 mmHg) in the isolated lung (n=4, Figure 
3.26). Additionally to the inhibition of HPV, rotenone induced a dose-dependent normoxic 
decrease in PAP of maximally 0.5 ± 0.2 mmHg at 170 nM (n=4). 
       
Figure  3.26 HPV and redox state at different rotenone concentrations in the isolated 
lung  
Data are given in percent of maximal reduction or maximum strength of HPV, respectively (% max. 
response). 
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However, as rotenone inhibits electron entry into the respiratory chain, effects on redox state 
would result in increased oxidation, which might only be seen under conditions of reduced 
cytochromes. In cell suspension, the mitochondrial cytochromes of PASMC could be less 
reduced in anoxia after application of rotenone than without rotenone. The difference in 
maximal possible reduction correlated well with the inhibition of HPV in intact lungs (Figure 
3.27). 
 
     
 
Figure  3.27 HPV and redox state at different rotenone concentrations in PASMC 
Inhibition of HPV compared to the maximal reduction of mitochondrial cytochromes at different 
rotenone concentrations in isolated pulmonary arterial smooth muscle cells (PASMC) 
Data are from n=5 experiments. 
 
 
3.2.4.1.4 Application of FCCP 
 
Uncoupling of mitochondrial respiration with FCCP resulted in no detectable alteration of 
redox state in isolated lungs. In isolated cells difference of normoxia and anoxic reduction 
increased with 4µM FCCP. Regarding HPV and normoxic vasoconstriction, FCCP induced 
dose-dependent alterations that did not correlate with redox state (Figure 3.28). 
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Figure  3.28 HPV and redox state at different FCCP concentrations in PASMC 
HPV and normoxic PAP compared to the maximal reduction of mitochondrial cytochromes at different 
FCCP concentrations in isolated pulmonary arterial smooth muscle cells (PASMC). 
Data are from n=4 experiments. 
 
 
    
3.2.4.2 Correlation of HPV with mitochondrial respiration during application of 
cyanide, HQNO, rotenone and FCCP 
In contrast to the cytochrome redox state in isolated lungs and cell suspensions of PASMC, 
inhibition of respiration by cyanide, HQNO and rotenone only partially correlated to 
alterations of the strength of HPV. During application of cyanide HPV was more decreased 
than respiration, whereas HQNO and rotenone inhibited respiration more than the strength of 
HPV. In presence of FCCP both, respiration and HPV initially increased, but their changes 
did not correlate in the further course of experiments (Figure 3.29, respiration is given during 
normoxia and at hypoxia [1% O2, pO2 8 mmHg]). 
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d) 
 
              
 
Figure  3.29 HPV and mitochondrial respiration in isolated PASMC in presence of 
mitochondrial inhibitors 
Data are from n=5 experiments each. 
 
 
3.3 Identification of non-mitochondrial cytochromes 
3.3.1 Cytochrome b558 of the NADPH oxidase 
 
Hypoxic difference spectra revealed only redox alterations of cytochromes of the 
mitochondrial chain, as identified by comparison to cyanide spectra and fitting of single 
mitochondrial spectra in sum difference spectra (see Figure 3.5 and 3.9). Reduction of 
cytochrome b558 of NADPH oxidase could be induced by addition of SDT to completely 
anoxic PASMC (Figure 3.30). The difference spectra in presence of SDT were in agreement 
to previously published cytochrome b558 spectra [203, 204]. 
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Figure  3.30 Spectrum of cytochrome b558 of the NADPH oxidase  
Comparison of fully reduced PASMC spectra (PASMC anoxia) with PASMC spectra after application 
of cyanide (PASMC cyanide) and cytochrome b558 (PASMC SDT). Reduction of cytochrome b558  was 
achieved by addition of sodium dithionite (SDT) to fully reduced PASMC (PASMC SDT). Data for SDT 
are from n=3 experiments. 
 
In the isolated lung reduction of cytochrome b558 of NADPH oxidase could be induced by 
perfusion of anoxically ventilated lungs with SDT (Figure 3.31). Mitochondrial cytochromes 
were pre-reduced with cyanide and do therefore not interfere with cytochrome b558. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.31 Identification of difference spectrum of NADPH oxidase in isolated lungs 
Spectra at different O2 concentrations and with additional perfusion with SDT are given. Mitochondrial 
cytochromes are inhibited with cyanide. For comparison a spectrum of cytochrome b558, obtained by 
addition of SDT to anoxic PASMC is depicted. n=3. 
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3.3.2 Cytochrome P450 
To limit amount of used CO these experiments were performed in isolated mouse lungs, as 
less amount of toxic gas was necessary for ventilation. In isolated lungs cytochrome p450 
could be identified by addition of CO to the inhaled gas (Figure 3.32). In contrast to isolated 
lungs, in isolated PASMC absorption changes of cytochrome P450 could not be illustrated by 
addition of CO (Figure 3.32).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.32 Carbon monoxide (CO) in isolated lungs and PASMC 
CO was applied at a concentration of 10% (pCO 75 mmHg) in a gas mixture with 21% O2 (pO2 158 
mmHg), balanced with N2 in PASMC and additionally 5% CO2 (pCO2 40 mmHg) in isolated lungs. n=3. 
For comparison mitochondrial cytochrome spectra obtained by addition of cyanide to the perfusate of 
the isolated mouse lung preparation are given, as well as difference spectra of oxygenated 
hemoglobin added to the perfusate minus oxygenated hemoglobin during ventilation with CO (10%, 
pCO 75 mmHg).    
 
3.3.3 Soluble guanylate cyclase 
In isolated lungs and PASMC a b-type cytochrome peaking at 423 nm was detected during 
application of CO (Figure 3.32). It resembles CO difference spectra of hemoglobin (Figure 
3.32) or sGC (see Table 3). Therefore in isolated PASMC the cytochrome peaking at 423 nm 
might reflect CO binding to sGC, whereas in isolated lungs also residual hemoglobin might 
contribute to spectral changes.  
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3.3.4 Myoglobin 
Considering published spectra from literature (see Table 3) no myoglobin could be detected 
in PASMC, neither during anoxia, nor during CO application. 
 
3.3.5 Hemoglobin 
Spectrophotometric measurements in isolated lungs were obscured by multiple tissue 
chromophores and scattering alterations. The most prominent cytochrome besides 
mitochondrial cytochromes was hemoglobin. Even in buffer-perfused lungs residual 
hemoglobin, which might result in the occurrence of a b-type cytochrome, cannot be 
excluded. It was possible to fit hemoglobin and mitochondrial cytochromes in sum difference 
spectra obtained from isolated lungs that showed clear signs of hemoglobin presence. When 
comparing the fitting result of fitting the hemoglobin spectrum together with that the 
mitochondrial spectra versus fitting the hemoglobin spectrum or mitochondrial spectra alone, 
the best fitting result was achieved by addition of all spectra to the fitting algorithm (Figure 
3.33). 
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Figure  3.33 Fitting of hemoglobin in isolated lungs 
Fitting of mitochondrial cytochromes (fit only mitos) and hemoglobin spectrum (fit only Hb) in sum 
difference spectrum (anoxic ventilation) of isolated lungs during anoxic ventilation. Fitting of both, 
mitochondrial and hemoglobin spectra (fit mito + Hb), resulted in best agreement with measured 
anoxic spectrum. Data are from n=5 experiments. 
 
 
Analysis of the fitting results revealed that the strength of HPV corresponded to the 
oxygenation of hemoglobin (Figure 3.34) and amount of residual hemoglobin (Figure 3.35).  
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Figure  3.34 Comparison of the strength of HPV and the oxygenation state of 
hemoglobin
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Figure  3.35 Comparison of HPV and amount of hemoglobin 
Hypoxic pulmonary vasoconstriction (HPV) of different experiments (exp. 1-5) is illustrated in 
comparison with amount of deoxygenated hemoglobin (Hb) at specific O2 concentrations. Data are 
from n=5 lung preparations (exp. 1-5) of lungs that showed signs of residual hemoglobin of different 
amount. 
 
 
Therefore in isolated lungs oxygenation state and amount of hemoglobin might modulate 
HPV. 
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4 Discussion 
Although mitochondria have long been thought to be involved in the O2 sensing process 
underlying HPV [84, 108, 119, 122, 135], the possible mechanisms of their contribution are 
not yet resolved. In particular, the high O2 affinity of mitochondria, ATP maintenance during 
HPV and contradictory findings of pharmacological complex IV inhibition have been 
considered to limit the importance of inhibition of mitochondrial respiration as a possible O2 
sensing mechanism [104]. Increased or decreased ROS production mainly at complex I 
and/or III are thought to be more promising pathways [14, 74, 86]. 
However, due to methodological limitations, it had thus far not been investigated if 
mitochondrial respiration and cytochrome redox state of the O2 sensing cells of HPV are 
compromised during hypoxia-induced alterations in isolated lungs and HPV.  
In the present study, remission spectroscopy was adapted to intact, isolated and blood-free 
perfused rabbit lungs to quantify redox alterations of mitochondrial cytochromes under 
graded hypoxia. Furthermore, combining this method with high resolution respirometry 
allowed correlation of the strength of HPV, as well as hypoxia-induced alterations in PASMC 
with respiration and cytochrome redox state of PASMC.  
 
The current experiments yielded the following results: 
• hypoxia induced HPV at O2 concentrations ≤ 10% (pO2 ≤ 75 mmHg) in isolated lungs 
and an increase of mitochondrial membrane potential, as well as mitochondrial matrix 
ROS production at O2 concentrations ≤ 3% (pO2 ≤ 23 mmHg) in isolated PASMC. 
• mitochondrial respiration of PASMC was inhibited at O2 concentrations ≤ 14% (pO2 ≤ 
105 mmHg), reaching ≥ 3 ± 0 % inhibition at O2 concentrations of ≤ 3% (pO2 ≤ 23 
mmHg). 
• cytochrome aa3 of complex IV was significantly reduced by ≥ 11 ± 3 %, cytochrome c 
by ≥ 10 ± 4 % at ≤ 3% O2 (pO2 ≤ 23 mmHg) in PASMC. 
• cytochrome bl/h was less reduced compared to cytochrome aa3 and c at O2 
concentrations  ≤ 3% (pO2 ≤ 23 mmHg) in PASMC. 
• RASMC differed from PASMC in that hypoxia inhibited their respiration less than that 
of PASMC and did not induce an increase of mitochondrial membrane potential or 
ROS production. 
• application of cyanide, HQNO and rotenone resulted in dose-dependent inhibition of 
mitochondrial cytochrome reduction, correlating with the strength of HPV. 
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These findings suggest that hypoxia causes inhibition of complex IV resulting in alterations of 
cytochrome redox state, that initiate mitochondrial matrix superoxide release from complex 
III, by concomitant increase in mitochondrial membrane potential. This conclusion is based 
on the following facts: 1) the hypoxia-induced decrease of mitochondrial respiration 
paralleled HPV in isolated lungs; 2) the cytochrome reduction of cytochrome c and aa3 
(complex IV) and respiration in PASMC correlated to the hypoxia-dependent increase in 
mitochondrial superoxide levels as well as mitochondrial membrane potential; 3) cytochrome 
bl/h (complex III) was less reduced during hypoxia compared to cytochrome c and aa3; 4) 
these alterations were specific for PASMC, as RASMC displayed a lower decrease in 
respiration and no rise in matrix superoxide release and mitochondrial membrane potential; 
5) pharmacological inhibition of mitochondria revealed analogous kinetics of cytochrome 
redox state and the strength of HPV. 
 
4.1 Remission spectrophotometry 
When measuring spectral alterations in lung tissue by remission spectrophotometry, the sum 
spectrum of all tissue cytochromes is detected. This included mitochondrial cytochromes, but 
also cytochrome b558 of NADPH oxidases, cytochrome P450 and cytochrome b of 
hemoglobin. In order to identify mitochondrial cytochromes in the isolated lung, the measured 
spectra were compared to published reference spectra and to difference spectra after 
application of specific inhibitors of the cytochromes. When comparing the spectral alterations 
in the lung at 0% O2 (pO2 0 mmHg) with the spectra of the cytochromes, clear attribution to 
mitochondrial cytochromes could only be found in the wavelength range of 600-610 nm for 
cytochrome aa3. In the other wavelength ranges, the spectra of different cytochromes 
showed overlapping features, making it difficult to distinguish mitochondrial from non-
mitochondrial cytochromes. To decrease the influence of hemoglobin as a prominent non-
mitochondrial cytochrome, lungs were flushed with perfusate until the hemoglobin spectrum 
was no longer visible. Only these lungs were used for qualitative evaluation of oxygen 
dependency of mitochondrial cytochromes. However, the possibility that the difference 
spectrum of residual hemoglobin contributed to the spectral changes cannot be completely 
discounted. In measurements of lungs that showed signs of hemoglobin, the amount and 
oxygenation state of hemoglobin was semiquantitatively analyzed by fitting of the known 
hemoglobin difference spectra in the sum difference spectrum. Addionally, cytochrome b558 
of NADPH oxidase peaking at 427 and 558 nm could not be distinguished from mitochondrial 
cytochrome bl/h with absorption maxima at 430 and 563/566 nm. However, reduction of 
Discussion 86
cytochrome b558 could only be detected by addition of SDT to anoxic tissue or cells, so that 
contribution of this cytochrome to the sum hypoxic spectrum is unlikely (see also 4.5). 
In tissue remission spectrophotometry the spectrum is not only altered by absorption of light, 
but also by wavelength dependent scattering and reflection. For scattering by particles 
similar to or larger than the applied wavelength (e.g. as it occurs in milk or biological tissue), 
the Mie theory of scattering applies [205, 206]. This phenomenon results in higher intensities 
of backscattered light at high wavelengths, as seen in the measurement of backscattered 
light in milk. Light is additionally influenced by reflection at boundary layers in tissue. This 
occurs, for example, when crossing compartments of high and low water content. 
Furthermore, particularly in lung tissue, the density of scattering and absorption particles 
varies with ventilatory excursions and edema, such that the detected spectrum could be 
altered. If the scattering properties, reflection and tissue density do not change, they are 
constant during normoxia and hypoxia and can be eliminated from the measured spectrum 
by calculation of difference spectrum. The measured difference spectrum then only reflects 
absorption characteristics of the tissue. To eliminate the influence of ventilation, spectra were 
averaged over one minute. However, tissue water content can change during measurement 
and affect scattering, reflection and - due to density - absorption properties and thus result in 
spectral alterations that are not due to redox changes. Such spectral alterations have been 
proven in the present work to occur by variation of tissue water content elicited by increasing 
pulmonary venous pressure or reducing the intravascular fluid load and tissue density by 
induction of vasoconstriction with the thromboxane mimetic U-46619. The resulting spectra 
resembled remission spectra of lung tissue. This suggests decreased absorption (during 
volume load) or increased absorption (during vasoconstriction by thromboxane) due to lower 
or higher density of absorption particles in the measurement volume and/or increased 
reflection. Therefore, changes in tissue water content either by alteration of vascular tone or 
pulmonary edema must be taken into account when evaluating the redox spectra. The latter 
effect was avoided in the current study by only using lungs that showed no signs of edema. 
The first effect cannot be avoided and must be considered during interpretation of the 
respective results.  
Therefore spectral alterations in the wavelength ranges of 410-440 nm and 520-590 nm may 
belong to non-mitochondrial cytochromes or scattering artefacts and only qualitative 
evaluation of spectral alterations in the lung seem to be adequate. However, when a high 
amount of hemoglobin is present and included into the fitting algorithm, semiquantitative 
evaluation of hemoglobin is possible due to its unique absorption characteristics at 590 nm 
and prominent absorbing character. The results of the less prominent cytochromes, with 
absorption features that overlap highly with other phenomena, particularly cytochrome bl/h 
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interfering with hemoglobin at 560 nm and vasoconstriction induced alterations at 430 nm, 
cannot be evaluated in the isolated lung. 
 
In contrast to the situation in the isolated lung, in cell suspensions of PASMC only 
mitochondrial cytochromes could be demonstrated. Reference absorption spectra for single 
cytochromes were determined in the closed chamber system by application of mitochondrial 
inhibitors and bovine cytochrome c. They resembled previously reported mitochondrial 
cytochrome difference spectra [207] (see also appendix). Thereby cytochrome aa3, bl/h and c 
could be identified. Cytochromes a and a3 could not be distinguished, as determined by 
differential reduction of cytochrome a with cyanide. This effect is suggested to be caused by 
a much greater contribution in absorption from cytochrome a compared to cytochrome a3 
(80-90%) [185]. Cytochrome c1 and b560 of complex II was also not visible as reported 
previously  [185].  
In PASMC only mitochondrial cytochromes aa3, bl/h and c contribute to the sum difference 
spectrum measured during anoxia, as 1) it was found that recalculation of a sum spectrum 
with the derived reference spectra resembled the measured spectrum and 2) the spectral 
alterations after application of cyanide, which specifically reduces mitochondrial 
cytochromes, was almost identical with hypoxia-derived spectra. 
For application of the fitting algorithm, therefore, cellular cytochromes of lower absorption 
coefficients that did not contribute detectably to the measured spectrum were neglected. 
Nevertheless, cytochrome b558 could be identified by reduction with SDT during anoxia, 
cytochrome P450 and sGC by CO. Other non-mitochondrial cytochromes (hemoglobin and 
myoglobin) could not be detected in PASMC (see 4.5). 
Based on the identified mitochondrial difference spectra, changes in redox state were 
determined as follows: Attenuation of light intensity (i.e. difference spectrum) in cell 
suspensions is a non-linear function of absorption and scattering. However, for small 
changes of absorption and sufficient narrow-band consideration, the approach of Lambert-
Beer, A(λ) ∝ ln(I0(λ)/Is(λ)), A(λ)= µa(λ) + µs(λ), can be applied as first order approximation (λ: 
wavelength, A: light attenuation, I0: intensity of incident light, Is: intensity of the backscattered 
light, µa(λ): absorption, µs(λ): scattering). According to this approximation, light attenuation 
depends linearly on absorption and scattering. The linear relationship between light 
attenuation and absorption was confirmed in the present experiments by successfully 
correlating difference spectra of cytochrome c with exogenously applied cytochrome c 
concentration in cell suspension. Absorption depends on chromophore concentration and 
redox state, scattering on particle size and concentration. Therefore, light attenuation (i.e., 
difference spectrum) is directly proportional to absorption when scattering is constant and 
conclusively directly proportional to changes in the redox state, when chromophore 
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concentration is constant. Changes in scattering cannot be completely controlled, as hypoxia 
may induce alterations of the shape of cells and/or mitochondria. However, since scattering 
effects are wavelength dependent, prominent scattering variations would result in differential 
absorption in the low and high wavelength ranges (415-460 nm and 500-620 nm, 
respectively), due to non-linear light attenuation in the low wavelength range. This was 
excluded in experiments with analysis of different wavelength ranges. However, only spectral 
measurements were included, in which differential calculation of low and high wavelength 
ranges showed identical results and spectral alterations of scattering could not be identified 
visually. The negligibility of the scattering effects was described previously in a similar 
system by Hollis et al. [185]. 
According to the above derived linear relationship between light attenuation, absorption and 
redox state, measured difference spectra were used to calculate changes in cytochrome 
redox states. Reference spectra of single cytochromes were fit in the measured sum 
difference spectrum by multi-wavelength least-square fitting. As the recalculated sum spectra 
were almost identical with the measured difference spectra, it can be concluded that the 
provided reference spectra were sufficient for semiquantitative evaluation of the contribution 
of the single cytochromes in the sum difference spectra.   
 
4.2 Mitochondrial complex IV in oxygen sensing of HPV 
In this study, mitochondrial respiration was inhibited at O2 concentrations ≤ 14% O2 (pO2 ≤ 
105 mmHg) in PASMC, correlating with the onset of HPV at ≤ 10% O2 (pO2 ≤ 75 mmHg) in 
isolated lungs. Therefore, although the high O2 affinity of mitochondria has been considered 
to exclude the inhibition of mitochondrial respiration as a possible mechanism underlying 
HPV in the past [104], inhibition of electron transfer to O2 at complex IV can act as an O2 
sensor. However, the O2 affinity is in the range of previously reported O2 affinities [199], 
which results in very small inhibition of respiration under mild hypoxia (≤ 3 ± 0 % at  ≥ 3% O2, 
pO2 ≥ 23 mmHg). This is in line with the previously suggested hypothesis, that the inhibition 
of mitochondria may  initiate a second messenger for O2 sensing (e.g. a change in ATP/ADP 
ratio), rather than energy depletion during hypoxia acting as an O2 sensing mechanism ([103, 
106, 120], see introduction).  
The redox alterations of complex IV (cytochrome aa3) in isolated PASMC found in the 
investigations of this thesis support the findings of the respiration experiments that inhibition 
of complex IV can act as an O2 sensor, as they 1) resembled the hyperbolic kinetics of 
respiration and 2) became significantly reduced at 3% O2 (pO2 23 mmHg) in parallel with  
hypoxia-induced mitochondrial membrane hyperpolarization, ROS production, and calcium 
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increase in PASMC [208]. In isolated lungs the reduction of complex IV is difficult to detect 
due to interference of multiple spectral alterations, including non-mitochondrial cytochromes, 
other cell types beside PASMC and scattering artefacts. The spectral changes detected in 
the isolated lung at a PAO2 of 10% O2 (pO2 75 mmHg) could not be observed in PASMC, 
which favors the suggestion that the spectral alterations in the wavelength range of 405-440 
nm in isolated lungs under mild hypoxia (10% O2, pO2 75 mmHg) are not attributed to 
cytochrome bl/h reduction in PASMC, but rather related to other cytochromes of the b class 
(hemoglobin, cytochrome b558) in other cell types or scattering-induced alterations due to 
vasoconstriction, as evoked by application of the thromboxane mimetic. However, reduction 
of mitochondrial cytochrome aa3, peaking at 445 nm and 603/605 nm, could be clearly 
distinguished from other spectral alterations and could only be detected at a PAO2 of 0 % O2 
(pO2 0 mmHg). Visual evaluation of the spectral alterations provided the same result as fitting 
of the spectra of cytochrome aa3, bl/h, c and hemoglobin in the hypoxic difference spectra of 
isolated lungs. 
Therefore, despite the difficulties of discrimination of the mitochondrial cytochromes in the 
isolated lung, it can clearly be stated that complex IV reduction is detectable at anoxic 
ventilation. Integrating the results of PASMC, in higher O2 concentrations small redox 
alterations of mitochondrial cytochromes can be expected, but are probably beyond the 
detection limit in the isolated lung. In summary, this study could show a small, but significant 
inhibition of respiration and reduction of complex IV in PASMC at O2 concentrations, which 
induce HPV and/or hypoxia-induced cellular alterations. 
In PASMC first hypoxia-induced alterations of mitochondrial membrane potential, ROS 
concentration and cellular calcium concentration were detectable at 3% O2 (pO2 23 mmHg), 
which correlated to a reduction of cytochrome c by 10 ± 4 %, cytochrome aa3 by 11 ± 3 % 
and respiration by 3 ± 0 %. Levels of hypoxia at which these alterations were detected in 
PASMC are well in line with the onset of HPV in the intact organ, since comparable O2 
values have been suggested to occur at the level of precapillary PASMC [3]. The range of 
onset of mitochondrial hyperpolarization and superoxide increase is similar to previous 
studies investigating the onset of hypoxia-induced cellular membrane depolarization, 
intracellular calcium increase and contraction of PASMC [21, 25]. Specifically the hypoxia-
induced calcium increase in rabbit PASMC was reported to occur at a pO2 of 16-21 mmHg 
(2-3 % O2)  [63] and of < 50 mmHg (7% O2) with glucose free medium [26]. Therefore this 
study shows that inhibition of electron transfer at complex IV and reduction of respiration 
occur at O2 concentrations that induce HPV, and it can be proposed that these alterations 
are initial steps of mitochondrial O2 sensing in PASMC. The degree of inhibition seems to be 
too small for metabolic inhibition, but may result in signal initiation, for example, by AMP-
dependent protein kinase activation [108], regulation of mitochondrial calcium release [209] 
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or ROS metabolism via regulation of cytochrome redox state. A subcellularly 
compartmentalized decrease of ATP, initiating a change in the redox state of the cell, has 
been suggested early to initiate HPV, due to the finding, that metabolic inhibition with 2-
deoxyglucose (2-DOG) and reduced glutathione (GSH) inhibit the hypoxia-induced inhibition 
of Kv channels, with the limitation however, that the effect of GSH was not selective for 
PASMC [24, 52]. The relevance for the localization of the mitochondria was recently  
emphasized [100], showing ATP- and magnesium dependent regulation of hypoxia sensitive 
Kv channels by near-by mitochondria [54]. Also in the O2 sensing process of the carotid body 
mitochondrial complex IV has been suggested to serve as O2 sensor for chemosensory 
discharge, as well as HIF-1α stabilization [179]. 
In contrast, in fibroblasts of patients with decreased respiration due to impaired function of 
complex IV (Leigh Syndrome), no impairment of HIF-1 stabilization was found, suggesting 
that ATP production is not required for O2 sensing [210]. 
Specifically in HPV, the importance of complex IV was questioned due to failure of cyanide to 
inhibit HPV in some investigations (see introduction, Table 1). However, this seems to be at 
least partially a dose dependent effect. In this study, cyanide inhibited HPV in the 
concentration range of 1-80 µM (see 3.2.4.1.1). 
 
4.3 Mitochondrial complex III in oxygen sensing of HPV 
Due to the reported contradictory findings regarding pharmacological inhibition of complex IV 
and studies with agents interfering with ROS pathways, an increased or decreased ROS 
production mainly at complex I and/or III of mitochondria by a yet unresolved mechanism has 
been proposed as a pathway for O2 sensing [14, 74, 86].  
In the present investigations, results are in favor of increased ROS production at complex III, 
because 1) increased oxidation state of cytochrome bl/h compared to cytochrome aa3 and c 
was found, and 2) increased mitochondrial membrane potential and ROS production 
correlated to changes of mitochondrial redox state. 
 
Cytochrome bl/h exhibited no signs of reduction even at severe hypoxia, whereas cytochrome 
c and aa3 had already been reduced. Although cytochrome bl/h has the lowest absorption 
coefficient according to these measurements, discernable changes were detectable 
according the equation for critical difference in the O2 range of ≤ 3% O2 (pO2 ≤ 23 mmHg). 
This finding is in agreement with a hypoxia-induced increase in mitochondrial superoxide 
production at the semiubiquinone site at complex III and thus HPV as previously suggested 
[118, 118, 130, 133, 134, 211]. Furthermore, the results are in accordance with recent data 
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from Moncada and colleagues, who demonstrated a more pronounced reduction of 
cytochrome aa3 and c compared to cytochrome bl/h in a monocyte cell line during inhibition of 
respiration by endogenous NO [212]. Increased mitochondrial membrane potential was 
suggested to support the resulting increase in ROS production [128], as also seen in the 
study presented in this thesis. Increased mitochondrial membrane potential may  be caused 
by increased glycolytic ATP production [130]. Another hypothesis assumes that the 
mitochondrial proton leak decreases with low O2 levels, leading to higher mitochondrial 
membrane potential than expected during hypoxia and, consequently, also to higher 
superoxide production [213].  
Although it is not clarified yet how mitochondrial membrane hyperpolarization is achieved, 
the finding of the hyperpolarization is in line with previous studies by  Michelakis et al. [23].  
However, in contrast to the investigations in this thesis, Michelakis et al. [23]measured a 
decrease in ROS production in pulmonary artery rings. One difference between the studies is 
the use of fluorescent dyes specific for intracellular, but not mitochondrial ROS production.  
As illustrated in the introduction, this contradictory finding may be explained by the possibility 
that changes in ROS are dependent on subcellular localization, time course and degree of 
hypoxia. In general, the results of the present study support the conclusion that increased 
mitochondrial ROS production occurs under conditions of high membrane potential, highly 
reduced ubiquinone pool and decreased respiration (see introduction). 
As a possible mechanism for ROS production at the quinol oxidase (Qo) site of complex III, 
an unstable semiubiquinone could bypass the Q-cycle and directly reduce O2, forming 
superoxide [214]. Inhibition of complex IV has been proposed to be  insufficient for this 
mechanism, as complex IV inhibition results in cytochrome c1 reduction, which may  
decrease electron inflow in complex III, due to a pivoting interaction of the iron-sulfur 
complex with cytochrome c1 and the Qo site depending on its redox state [133]. 
Thus, ROS production from complex III during complex IV inhibition appears to require an 
additional defect that increases oxidant production from the Qo site of complex III. Functional 
alterations of the Qo site can disrupt electron flux in this portion of complex III leading to 
“bypass reactions” of the Qo site that enhance ROS production, with the rate-limiting step 
being the formation of a reactive species (probably a semiubiquinone), but not availability of 
O2 [214]. However, it is not yet certain, which functional alterations of the Qo site this could 
be under condition of hypoxia. 
Another hypothesis questions this mechanism of semiubiquinone directly reducing O2, as it 
doubts the existence of relevant amount of free semiubiquinone at the Qo site. It  proposes a 
reverse reaction of electron transfer from reduced cytochrome b onto O2 via ubiquinone 
[211]. Conditions of ROS production would be favored by a partially oxidized ubiquinone pool 
to provide sufficient amounts of the redox mediator and a moderately high membrane 
Discussion 92
potential to increase the fraction of reduced heme bL. In organs like the lung, where the 
ubiquinone pool is normally too oxidized for efficient ROS generation, already moderate O2 
limitation could directly increase the fraction of reduced ubiquinone to the critical level of 
about 75% ubiquinol. This would result in a burst of ROS production setting off the hypoxia 
signaling cascade [211]. 
 
Although the current work cannot exclude the relevance of ROS production from complex I  
for O2 sensing, Qo site of complex III has been suggested to be the dominant ROS 
production site, because ROS products are directed into the intermembrane space away 
from the antioxidant defenses of the matrix [133]. In this regard it has to be considered, that 
the measurements with MitoSox are limited for evaluation of this kind of mitochondrial ROS 
production, as MitoSox mainly determines mitochondrial matrix ROS production. Additionally 
MitoSox has to be judged critically under the conditions of this study, as its accumulation 
depends on mitochondrial membrane potential [215]. An effect, which may prove beneficial in 
this regard, may be that residual MitoSox in the cytosol and intermembrane space could 
contribute to the ROS signal and therefore also detect ROS released into the intermembrane 
space. This could explain the discrepancy with the measurements of Schumacker, who 
recently showed that ROS increased in cytosol and intermembrane space, but decreased in 
mitochondrial matrix in PASMC and systemic cells [216]. Furthermore it is also generally 
accepted, that the Qo site of complex III also releases ROS to the mitochondrial matrix site by 
an unresolved mechanism, and that the quinone reductase (Qi) site can produce ROS, albeit 
to a much lower degree than at the Qo site due to a higher stability of the semiubiquinone 
[132]. A convincing approach recently used siRNA against the iron-sulfur-complex of 
complex III, also demonstrating that the Qo site of complex III is required for hypoxic 
stabilization of HIF-1 [140].  
 
4.4 Comparison of PASMC to arterial smooth muscle cells of the 
systemic vasculature 
The present study found no evidence for differences between PASMC and ASMC with 
regard to redox alterations or O2 affinity. ASMC exhibited a smaller  increase in mitochondrial 
membrane potential, no increase in ROS concentration and no calcium release [208]. 
RASMC, that also showed no hypoxia-induced increase in calcium or ROS concentration, 
differed from PASMC in the higher O2 affinity and missing hypoxic mitochondrial membrane 
hyperpolarization, but not in mitochondrial redox state. Thus, it can be speculated, that for 
sufficient ROS release, an increase in mitochondrial membrane potential above a certain 
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threshold in combination with increased oxidation state of cytochrome bl/h is necessary. Only 
in the case of PASMC, when mitochondrial membrane potential and ROS release is 
increased, a hypoxia-induced intracellular calcium increase was detected [208]. The larger 
inhibition of respiration in hypoxia of PASMC compared to RASMC may promote these 
changes. However, specific downstream regulation of PASMC, (e.g. by different ion channel 
expression [217]) or specific regulation of ion channel function [218] may  also underlie the 
differences between the cell types. The similar hypoxic behavior of PASMC and ASMC may 
be due to the fact, that ASMC are - like PASMC - exposed to rather high pO2 in vivo with the 
aorta carrying well oxygenated blood.   
 
A role of the culture conditions for the observed effects was largely excluded as only cells 
from passages 1 and 2 were used, no differences between these passages were detectable, 
and cultured cells showed expected physiological responses, e.g. with regard to the hypoxia-
induced intracellular calcium increase [208]. 
 
4.5 Mitochondrial inhibition and HPV 
The data presented in this study favor the conclusion that inhibition of respiration and 
reduction of mitochondrial cytochromes initiate signaling cascades in HPV. Differential 
regulation of the cytochromes may be essential for the signaling mechanism, as cytochrome 
bl/h was less reduced in hypoxia compared to cytochrome aa3 and c. 
This hypothesis was investigated using inhibitors of the mitochondrial respiratory system that 
specifically prevent HPV (see introduction).  
Application of cyanide in intact lungs decreased the strength of HPV to a similar degree as it 
induced mitochondrial cytochrome reduction. Cytochrome bl/h was significantly less reduced 
than was cytochrome c, suggesting that a differential regulation of redox states occurs also in 
the intact lung under condition of complex IV inhibition. In presence of HQNO, a dose-
dependent reduction of cytochrome bl/h and oxidation of cytochrome c correlated well with the 
inhibition of HPV in isolated lungs. Rotenone did not result in any detectable changes of 
redox state during ventilation with normoxic or hypoxic gas of 3% O2 (pO2 23 mmHg) in the 
isolated lung. This can be explained by the fact that rotenone inhibits electron inflow into the 
respiratory chain and, therefore, no further oxidation could be detected [184] when the 
cytochromes are already completely oxidized in normoxia. Because mitochondrial 
cytochromes were also not significantly reduced at 3% hypoxia (pO2 23 mmHg) in isolated 
lungs, inhibition of reduction (i.e. oxidation) could also not be measured during rotenone 
treatment in isolated lungs at this O2 concentration. In contrast, cytochromes in isolated 
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PASMC were fully reduced in anoxia, and inhibition of electron inflow into the respiratory 
chain by application of rotenone resulted in decreased maximal possible reduction (i.e. 
higher oxidation compared to completely reduced anoxic cytochromes without rotenone). 
Furthermore in PASMC maximal possible reduction of the cytochromes during anoxia was 
decreased in a concentration-dependent manner by rotenone, and this inhibition correlated 
to HPV inhibition in the isolated lung. As anoxia cannot be achieved in the isolated lung, the 
effect of rotenone can only be measured and correlated to HPV in PASMC. In presence of 
cyanide and HQNO cytochrome redox state correlated to the strength of HPV in isolated 
lungs and to decreased redox alterations from normoxia to anoxia in PASMC. Small 
discrepancies between redox alterations in PASMC and inhibition of HPV may be due to 
different pharmacodynamics in isolated lungs and isolated cells. 
In contrast to cytochrome reduction, the level of mitochondrial respiration in PASMC did not 
correlate to the strength of HPV, which supports the hypothesis that inhibition of 
mitochondrial respiratory chain initiates HPV, but subsequent regulation of cytochrome redox 
state is essential for signal transduction of HPV. The role of cytochrome bl/h was also 
highlighted by the inhibitor studies, as relative cytochrome bl/h oxidation is found during 
cyanide inhibition in the isolated lungs. 
It remains unclear, how the differential regulation of cytochrome redox state and respiration 
is achieved. 
Results of FCCP application support the importance of an intact mitochondrial membrane as 
a prerequisite for HPV. In high concentrations FCCP inhibited HPV, but did not change 
respiration or cytochrome reduction substantially. Therefore, it is concluded that, disruption of 
mitochondrial membrane potential by the uncoupling substance FCCP caused inhibition of 
HPV inhibition.  
 
4.6 Identification of non-mitochondrial cytochromes 
In isolated cells, only spectral alterations caused by mitochondrial cytochromes could be 
detected upon application of hypoxia. This was verified by comparison of hypoxic spectra 
with a) cyanide spectra, b) published mitochondrial spectra and c) spectra derived after 
application of inhibitors specific for complex III or IV. Nevertheless, non-mitochondrial 
cytochromes could be identified in PASMC and isolated lungs by application of certain 
interaction partners causing spectral shifts of non-mitochondrial cytochromes. In particular, 
reduced spectra of NADPH oxidase were visible after application of SDT to anoxic PASMC. 
It has been previously described  that reduction of cytochrome b558 of NADPH oxidase is only 
observed to be rapid under anaerobic conditions when stimulated by NADPH [193].  
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Otherwise it is slow and  incomplete even after several minutes of anoxia, due to 
conformational properties that allow electron inflow into the complex only in the presence of 
O2 [219]. There was a question  whether reduction of cytochrome b558 provides insight into 
activity of NADPH oxidases at all [220]. 
Application of CO allowed demonstration of cytochrome P450 in isolated lungs, but not in 
isolated PASMC. As cytochrome P450 has, however, been shown to 1) be present in 
PASMC, 2) produce HETE [221], and 3) play a modulatory role in Kv channel activity [168], 
the concentration of cytochrome P450 may  be too low to be identified in the experiments 
with addition of CO by the spectroscopic methods in the current  study. In isolated lungs, no 
spectral alterations could be found at 450 nm during hypoxic ventilation, which indicates that 
binding of endogenous CO to cytochrome p450 does not occur in hypoxia. It therefore has to 
be taken into account that binding of endogenously produced CO could be obscured by 
relative low levels of cytochrome P450 compared to cytochrome aa3, peaking at 445 nm. 
Furthermore, it cannot be excluded that cytochrome P450 plays a modulatory role in HPV via 
CO metabolism in the isolated lung. Substrate binding to cytochrome P450 (e.g. during 
activation of NADPH-dependent cytochrome P450 reductase-heme oxygenase signaling) 
may  change the difference spectrum of the cytochrome P450, with a decreased or increased 
absorption at 420 nm ("type I" difference spectrum) or at 430 nm ("type II" spectrum) [222]. 
Such alterations could not be distinguished from other cytochromes in the isolated lung, but 
could also not been identified in isolated PASMC. Therefore, within the limitations of the 
detection method, this study did not provide any evidence that cytochrome P450 played a 
role in O2 sensing in PASMC. This is in line with a previous study excluding a role of the 
cytochrome P450 reductase-hemoxygenase-BKCa-pathway as O2 sensing mechanism by use 
of genetically modified mice [177]. Although cytochrome P450 seems not to be involved in O2 
sensing, the importance of the cytochrome P450-induced production of EETs as a modulator 
for HPV and pulmonary hypertension is well known [172], but may  be beyond the detection 
limit of the applied spectrophotometric method in the isolated lung. 
Spectral alterations that indicate involvement of sGC during O2 sensing could not be 
detected in PASMC. Although a b-type cytochrome peaking at 423 nm correlating to spectral 
alterations caused by sGC (see Table 3) could be detected during application of CO in 
PASMC, these alterations were not present during hypoxia. NO binding would be expected 
to shift the absorption maximum of sGC from 431 nm (non-bound) to 398 nm (bound) [223], 
but could not be found in PASMC. Hypoxia can shift the absorption maximum of sGC from 
416 to 430 nm with maximal difference at 437 nm [189]. Although it is not possible to 
distinguish these alterations from other b-type cytochromes, (e.g. cytochrome bl/h of complex 
III), sGC seems unlikely to play a role in PASMC given that the hypoxic spectrum resembles 
the cyanide spectrum.  However, cyanide is not expected to cause spectral shifts of sGC.  
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 The current investigations revealed no signs of the presence of myoglobin, neither in 
isolated lungs, nor in PASMC. It was not too long ago, when the existence of myoglobin in 
mammalian smooth muscle cells was discovered. However, it remains unclear, if this is also 
true for smooth muscle cells of pulmonary arteries, as in the cited study mRNA of myoglobin 
was not demonstrated in lung tissue [224]. 
The presence of hemoglobin measured in the isolated lung was found to be the only relevant 
non-mitochondrial cytochrome for modulation of HPV. Although methodologically 
challenging, it was successfully established that oxygenation state and amount of 
hemoglobin correlate with HPV. This fits  the finding, that free oxygenated hemoglobin can 
scavenge NO, thereby enhancing HPV [225], yet deoxygenated hemoglobin can produce NO 
[226]. Considered with the results of the current thesis, it can be concluded that the sigmoidal 
stimulus-response relationship between pulmonary arterial pressure and the level of hypoxia 
could be the result of enhanced HPV in mild hypoxia by oxygenated Hb and attenuated HPV 
in severe hypoxia by deoxygenated Hb. It is important to mention, that even in visually 
hemoglobin-free perfused isolated lungs, spectral signs of persistent existence of 
hemoglobin are proven by spectrophotometry. Therefore even small amounts of hemoglobin, 
which went undetected in previous studies, could result in the different dynamics of HPV in 
isolated lungs versus pulmonary arteries or PASMC.  
 
 
4.7 Conclusion 
In conclusion, a new spectrophotometric technique was established in the presented work. 
This allows for the first time, to the best of the author's knowledge, the detection of O2-
dependence of mitochondrial respiration and redox state in isolated lungs, PASMC, ASMC 
and RASMC. As summarized in Figure 4.1, a small but significant decrease in mitochondrial 
respiration (1) and reduction of cytochrome c and aa3 of complex IV (2) was found in the O2 
range of HPV and/or hypoxic reactions of PASMC. Thus, despite the high O2 affinity of 
mitochondria, inhibition of mitochondrial respiration may act as a sensor in acute pulmonary 
O2 sensing by O2 deprivation at the physiological electron transfer site (complex IV).  This 
may result in an increased electron backup and leak at complex III, indicated by an increased 
oxidation level of cytochrome bl/h. Together with increased mitochondrial membrane potential 
(3a) this can result in subsequent ROS production (3b) and increased cytosolic calcium 
levels. The higher O2 affinity of RASMC and lower hypoxic mitochondrial membrane potential 
compared to PASMC and ASMC supports the hypothesis of differential mitochondrial 
behavior in different cell types. Modulation of HPV by hemoglobin (4) may play an important 
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role in isolated lungs. Alternative yet unidentified or established non-mitochondrial 
cytochromes were not detected, and thus are unlikely to be involved in O2 sensing underlying 
HPV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  4.1 Proposed mitochondrial pathway of oxygen sensing in HPV 
For explanation please refer to the text.
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5 Summary 
Hypoxic pulmonary vasoconstriction (HPV) is an essential mechanism of the lung to match 
blood perfusion to alveolar ventilation and optimize pulmonary gas exchange. Mitochondria 
have been suggested as possible O2 sensors of HPV. With regard to mitochondria the 
hypothesis of an increased or decreased production of reactive oxygen species (ROS) at 
complex I or III competes with the hypothesis of a localized small decrease of ATP 
production. Against this background, the present study investigated the O2 dependent 
regulation of mitochondrial cytochrome redox state and respiration in isolated lungs and 
pulmonary arterial smooth muscle cells (PASMC). 
 
Methodological limitations of the past were overcome by detection of mitochondrial 
cytochrome redox state under hypoxic and normoxic conditions using remission 
spectrophotometry in intact lungs and in PASMC. High-resolution respirometry was used to 
determine the respiration simultaneously in isolated cells. These alterations were compared 
to HPV and hypoxia-induced cellular responses, such as mitochondrial matrix superoxide 
release and mitochondrial membrane potential. Aortic and renal arterial smooth muscle cells 
(ASMC, RASMC) served as controls.  
 
The hypoxia-induced decrease of mitochondrial respiration paralleled the increase in the 
strength of HPV in isolated lungs. In PASMC, reduction of respiration and mitochondrial 
cytochrome c and aa3 (complex IV) matched an increase in matrix superoxide levels, as well 
as mitochondrial membrane hyperpolarization. Cytochrome bl/h (complex III) was relatively 
more oxidized during hypoxia compared to cytochrome c and aa3. In contrast to PASMC, 
RASMC displayed a smaller decrease in respiration and no rise in superoxide or 
mitochondrial membrane potential. Pharmacological inhibition of mitochondria revealed 
analogous kinetics of cytochrome redox state and the strength of HPV. 
 
The data of this thesis thus suggest inhibition of complex IV as an essential step in 
mitochondrial O2 sensing of HPV. Concomitantly, increased superoxide release from 
complex III and mitochondrial membrane hyperpolarization may initiate the pathway 
underlying HPV. 
In isolated lungs, HPV may be modulated by oxygenation state of hemoglobin, whereas 
there is no evidence for carbon monoxide playing a role via cytochrome P450. 
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6 Zusammenfassung 
Die hypoxische pulmonale Vasokonstriktion (HPV) ist ein wesentlicher Mechanismus der 
Lunge, um die Perfusion an die alveoläre Ventilation anzupassen und so den pulmonalen 
Gasaustausch zu optimieren. Mitochondrien sind dabei möglicherweise die 
Sauerstoffsensoren der HPV. Derzeit bestehen konkurrierende Hypothesen bezüglich eines 
mitochondrialen Sensing-Mechanismus: Eine erhöhte oder erniedrige Produktion von 
Sauerstoffradikalen am Komplex I oder III oder eine lokalisierte, leichte Abnahme der ATP 
Produktion könnten die Signalkaskade einleiten. Vor diesem Hintergrund, untersuchte die 
vorliegenden Arbeit die sauerstoffabhängige Regulation des Redox-Status’ mitochondrialer 
Cytochrome und der mitochondrialen Atmung in der isoliert perfundierten und ventilierten 
Lunge und in glatten Muskelzellen pulmonalarterieller Gefäße (PASMC). 
 
Methodische Limitationen bisheriger Untersuchungen wurden durch die Anwendung von 
Remissionspektrometrie überwunden, wodurch der Redox-Status mitochondrialer 
Cytochrome während Hypoxie und Normoxie in intakten Lungen und PASMC bestimmt 
werden konnte. Mit hochauflösender Respirometrie wurde gleichzeitig die Atmung in 
isolierten Zellen erfasst. Veränderungen dieser Parameter wurden mit der Stärke der HPV 
und Hypoxie-induzierten zellulären Antworten in isolierten Zellen, wie Superoxidfreisetzung 
in der mitochondrialen Matrix und dem mitochondrialen Membranpotential, verglichen. Zur 
Kontrolle wurden glatte Gefässmuskelzellen der Aorta und der Nierenarterie (ASMC, 
RASMC) herangezogen. 
  
Eine hypoxie-induzierte Abnahme der mitochondrialen Atmung erfolgte gleichzeitig mit 
Beginn der HPV in der isolierten Lunge. In isolierten PASMC ging die Abnahme der Atmung 
und Reduktion der mitochondrialen Cytochrome c und aa3 (Komplex IV) mit einem Anstieg 
der Superoxidkonzentration in der mitochondrialen Matrix, sowie einer mitochondrialen 
Membranhyperpolarisierung einher. Cytochom bl/h (Komplex III) war bezogen auf Cytochrom 
c und aa3 unter Hypoxie mehr oxidiert. Im Gegensatz zu PASMC, zeigten RASMC eine 
niedrigere Abnahme der Atmung und keinen Anstieg von Superoxid oder dem 
Membranpotential unter Hypoxie. Während pharmakologischer Inhibierung der 
Mitochondrien korrespondierte der cytochromale Redox-Status mit der Stärke der HPV. 
 
Die Daten der vorliegenden Arbeit legen daher nahe, dass die Inhibierung von Komplex IV 
ein wesentlicher Schritt beim mitochondrialen Sauerstoffsensing der HPV ist. Gleichzeitig 
könnte ein Anstieg der Sauerstoffradikalfreisetzung von Komplex III und des mitochondrialen 
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Membranpotentials die der HPV zugrunde liegende Signaltransduktion initiieren. In isolierten 
Lungen ist die HPV ausserdem möglicherweise durch den Oxygenierungstatus des 
Hemoglobin moduliert, während es keinen Hinweis darauf gibt, dass Kohlenmonoxid mittels 
Cytochrome P450 Interaktion eine Rolle spielt.
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8.1 Published reference spectra 
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Figure  8.1: Published reference difference spectra  
Reference spectra (reduced minus oxidized) are derived from the following sources: Liao et al. [227], 
Huang et al. [228], Palmer et al. [229] and University College London: 
http://www.medphys.ucl.ac.uk/research/borl/research/NIR_topics/spectra/spectra.htm. Stand: 
10.10.2010 
8.2 Measured reference spectra 
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Figure  8.2 Measured reference difference spectra  
Reference spectra (reduced minus oxidized) derived by application of mitochondrial inhibitors (see 
3.1.3) 
l/h 
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